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ABSTRACT OF DISSERTATION

CHARACTERIZATION OF SPONTANEOUS HYPERTENSION
IN CHLOROCEBUS AETHIOPS SABAEUS,
THE AFRICAN GREEN MONKEY
Hypertension is a complex multifactorial pathology that is a major risk factor for
the development of cardiovascular disease, stroke, and end stage renal disease. In the
United States, hypertension affects over 1 in 3 adults and comprises an annual cost of
over $58 billion in the healthcare industry. While remarkable strides in the diagnosis and
treatment of hypertension have been made since the pathology was first treated in the
1960s, a remarkable 13% of patients with elevated blood pressures are classified as
resistant hypertensive, where blood pressure remains uncontrolled while on three or more
classes of anti-hypertensive drugs. This treatment gap suggests that researchers need to
develop and utilize translational models that recapitulate the pathologies seen in patient
populations. Non-human primates (NHP) are highly similar to humans in terms of
physiology, circadian rhythmicity, behavior, and gene sequence and structure.
Development of NHP models that spontaneously develop pathologies, like spontaneous
hypertension, provide novel and vital tools to studying disease. Overall, this dissertation
is a comparative analysis of the mechanisms that drive the development of spontaneous
hypertension in Chlorocebus aethiops sabaeus, an Old World non-human primate, and
known mediators of essential hypertension in human populations. Chapter 2 presents how
hypertensive (HT) African Green Monkeys (AGMs) are older, with elevated heart rates,
increased renal vascular wall/lumen ratios, and altered glomerular morphologies
compared to normotensive (NT) controls. Chapter 3 describes metabolic studies
performed in a large cohort of animals that identified elevated proteinuria and ion
excretion in HT AGMs compared to NT animals. Chapter 4 focuses on the contribution
of sympathetic nervous system to the development of hypertension in this animal model
and describes the significant left ventricular hypertrophy and elevation of adrenergic
receptor mRNA in HT AGMs. Chapter 5 examines how age affects hypertension and
renal function in the NT and HT AGMs. Together these data provide a foundational basis
for the development of spontaneous hypertension in the AGM and provide a novel
translational model for the study of cardiovascular disease.
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CHAPTER ONE
HYPERTENSION AND THE AFRICAN GREEN MONKEY
Megan K. Rhoads1
1

University of Kentucky, Lexington KY 40506

Keywords: blood pressure control; hypertension; African green monkey;

1.1 Introduction
Hypertension is a complex, multifactorial disease that affects over 85 million
adults in the United States and an estimated 972 million people worldwide (Benjamin,
Blaha et al. 2017). Hypertension is a major risk factor for the development of
cardiovascular disease, stroke, and chronic kidney disease and treatment for hypertension
alone is estimated to exceed $200 billion in direct medical costs by the year 2030
(Heidenreich, Trogdon et al. 2011). Multiple risk factors have been identified in the
development of hypertension including but not limited to: age, race/ethnicity, family
history of high blood pressure, genetic factors, excess weight, decreased physical activity,
tobacco usage, stress, diet, education, and socioeconomic status (Benjamin, Blaha et al.
2017). In short, hypertension is a major global disease burden that adversely affects
millions of people and is the predominant modifiable risk factor associated with
cardiovascular mortality.
The American Heart Association (AHA) has historically defined hypertension as
systolic blood pressure (SBP) greater than 140 mmHg or diastolic blood pressure (DBP)
greater than 90 mmHg. A recent report from the AHA in conjunction with the American
College of Cardiology recommends that the clinical benchmark for the diagnosis of
hypertension be lowered to SBP greater than 130 mmHg or DBP greater than 80 mmHg,
due to marked differences in mortality(Whelton, Carey et al. 2018).
While the etiology of essential hypertension is still unknown, the pathological
consequences that occur due to hypertension have real effects on human health and life
expectancy. Hypertension primarily contributed to the death of 78,000 people in 2015
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and is considered the most important modifiable risk factor against cardiovascular
disease, stroke, and chronic kidney disease (Benjamin, Virani et al. 2018). In addition,
organ damage from hypertension in humans is particularly complex due to the
comorbidities and variations in severity of hypertension.
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1.2 Blood pressure control mechanisms

1.2.1 Cardiovascular function and pathologies
Discussion of normal cardiovascular function must begin with the physiological
application of Ohm’s Law (V= I * R) to the calculation of blood pressure. BP is defined
as the pressure exerted on the vessel walls by circulating blood. BP is also the
mathematical product of cardio output (CO) multiplied by total peripheral resistance
(TPR), the sum of the resistance of all vessels in the body. CO is the mathematical
product of stroke volume (SV) and heart rate (HR). The primary determinates of SV are
ventricular end-diastolic volume (EDV), and myocardial contractility. EDV, the volume
reached by the ventricular chamber prior to contraction, is determined by venous
pressure, which is related to both blood volume and venous smooth muscle tone. Changes
in any one of these variables will result in alterations in total blood pressure or a
compensatory response in another variable.
The Frank-Starling law of the heart governs the relationship between SV and
EDV. SV increases in response to increased EDV, or preload, allowing cardiac output to
be synchronized with venous return without extrinsic regulation. This mechanism of the
heart also couples left and right ventricular output to maintain balance between the
pulmonary and systemic circulations. Increases in afterload, or TPR, lower the FrankStarling curve of the heart, decreasing both stroke volume and left ventricular EDV, as
the atrial value cannot open until ventricular pressure exceeds pressure in the circulation.
As a consequence of increased afterload and decreased SV, preload is subsequently
increased due to the blood remaining in the ventricle after contraction.
4

Afterload increases when systemic vascular resistance increases, by stenosis in
the aorta, or by ventricular dilation. Chronic increased afterload can promote hypertrophy
of the myocardial wall in order to generate more force against circulatory pressure.
Hypertrophy allows more sarcomere units to share the increased wall stress caused by
increases in afterload and thus can be considered a physiological compensatory response
to increased BP.
Changes in HR can also affect BP. HR is set by the activity of pacemaker cells in
the primary sinoatrial (SA) node and the secondary atrioventricular (AV) node. Action
potentials are spontaneously generated by the SA node and travel through gap junctions
to the myocardial cells, beginning their depolarization and eventual action potential
associated contraction. The AV node is depolarized after the SA node, and transmits
action potentials to the ventricular cardiomyocytes. While the aptly termed ‘pacemaker’
cells are capable of spontaneous generation of action potentials, their timing is often
augmented by activity from the sympathetic and parasympathetic nervous systems.
Stimulation of the SA node by norepinephrine from the sympathetic nervous system
increases the heart rate while parasympathetic activation via acetylcholine decreases the
firing rate of the SA node through hyperpolarization.
Left ventricular hypertrophy (LVH) has long been established as a risk factor for
the development of chronic heart failure and a pathological consequence of hypertension.
Pathological LVH increases the oxygen demand of the cardiac tissue, decreases
mechanical efficiency via reduced compliance and can impair filling, leading to heart
failure. Studies in human hypertensive patients have demonstrated associations between
LVH and increased cardiac sympathetic outflow (Schlaich, Kaye et al. 2003). In addition,
5

the reduction in LVH observed in two-kidney one-clip hypertensive Wistar rats after
administration of β1-adrenergic antagonists suggests that sympathetic activity is crucial
to the development of LVH (Rizzi, Guimaraes et al. 2014).
TPR can be mediated by changes in vascular compliance, hormonal systems such
as the renin-angiotensin system, or local vasoactive effectors produced by the
endothelium or vasculature. Poiseuille’s law describes the inverse relationship between
pressure gradients and resistance in tubular flow (Poiseuille 1846). Factors such as vessel
length, viscosity, and radius all affect resistance in blood vessels; however, resistance is
governed primarily by radius size due to the exponential relationship found in
Poiseuille’s equation, revealing that any mediator which alters vessel radius can have
profound effects on TPR and thus blood pressure. This law in particular illustrates the
immense power of the vasoconstriction and vasodilation and the crucial importance of
systems that can affect vessel radius in the regulation of blood pressure.
Increased BP also has detrimental effects on the vasculature. Increased wall stress
on the vessels can lead to vascular remodeling, inducing hypertrophy and fibrosis. This
remodeling can lead to reduced arterial compliance, arterial stenosis, and tissue ischemia
(Intengan and Schiffrin 2001). Increased BP and increased turbulent flow due to changes
in vessel radius can also damage the vasoactive vascular endothelium, leading to
inflammatory cascades and decreases in nitric oxide and prostacyclin availability, which
typically oppose the vasoconstrictive adrenergic tone of the vessels (Luscher 1990, Kang
2014), creating a feed-forward mechanism that promotes increased BP.

6

1.2.2 Renal function and pathologies
The kidneys have long been considered critical to the maintenance of blood
pressure due their role in the regulation of fluid homeostasis, an idea introduced by
Claude Bernard and refined by Walter B. Cannon(Cooper 2008). Increases in blood
volume would increase preload, SV, and CO, resulting in increased BP. The kidney, as
the main excretory organ in the body, controls extracellular fluid volume and thus, blood
volume. Blood enters the kidney through the renal artery and traverses down the arterial
tree to the main filtering unit of the kidney, the nephron. In the renal corpuscle, composed
of the glomerular capillaries surrounded Bowman’s capsule, blood is filtered through the
capillary fenestrations, glomerular basement membrane, and filtration slits created by
podocytes. Plasma proteins remain in the blood due to the size and charge of the filtration
membranes. Once the filtrate is created, it moves down the tubule of the nephron towards
the collecting ducts of the kidney to ultimately become urine. Throughout the nephron,
diffusion and ion gradients are utilized to concentrate urine and maintain appropriate
extracellular concentrations of water, proteins, and ions. As filtrate moves down the
tubular lumen, key proteins, ions, and water are reabsorbed, secreted, and diffused
through multiple mechanisms using both active and passive transport.
The variables that determine glomerular filtration rate (GFR) can be described
mathematically by the following equation: 𝐺𝐹𝑅 = 𝐾& × (𝑃+ − 𝑃- − Π+ + Π- ); where
Kf is the filtration constant, PG is glomerular pressure, PB is the pressure within
Bowman’s capsule, ΠG is glomerular oncotic pressure, and ΠB is the oncotic pressure of
Bowman’s capsule. GFR is a clinical measure of kidney function and important to the
regulation of extracellular fluid volume.
7

Renal damage and hypertension have long been associated. It’s logical that
increased levels of renal perfusion pressure would result in larger forces being enacted on
the nephron. Chronic elevation of blood pressure would have detrimental effects on the
morphology of the glomerulus and the ability to create filtrate from urine. In normal
healthy adults, GFR is approximately 125 mL/min and is estimated by measuring serum
creatinine and the use of an estimation formula such as the Cockcroft-Gault or
Modification of Diet in Renal Disease equation. It is worth noting that high levels of
intra- and inter-individual variation in GFR estimation have called into question the use
of serum creatinine as a reliable marker of GFR, however, most clinical measurements
still utilize creatinine(Shemesh, Golbetz et al. 1985). GFR declines normally with aging,
decreasing by approximately 10 mL/min/decade after the age of 40(Glassock and
Winearls 2009). GFR is typically decreased in patients and experimental animals models
of hypertension and chronic renal failure compared to normal controls (Baylis 1994,
Ofstad and Iversen 2005, Astor, Matsushita et al. 2011).
Sympathetic outflow to the kidney has been shown to increase tubular sodium
reabsorption, active the RAAS, promote sclerosis of the glomerular capillaries, and
increase renal vascular resistance (Schlaich, Socratous et al. 2008). When pathologically
elevated and coupled with the volume expanding effects of the RAAS, this can create a
feed-forward mechanism that promotes vascular hypertrophy and glomerular damage. As
mechanical forces increase in the glomerulus, driven by increased blood volume and/or
pressures (PG), mesangial cells and podocytes undergo hypertrophy and eventual
failure(Nagata and Kriz 1992). Failure and atrophy of these cells leads to a lack of
filtration (KF) in the glomerulus allowing large proteins to move into the tubular lumen.
8

Ang II is a potent vasoconstrictor that has been shown to promote fibrotic growth
in tubular, mesangial, and interstitial cells, and promote the activation and recruitment of
inflammatory cells (Mezzano, Ruiz-Ortega et al. 2001). The inflammatory and fibrotic
changes in the nephron induced by Ang II can promote proteinuria, tubular atrophy, and
renal failure. Studies in the SHR suggest that tubular and glomerular damage develop in
parallel in the context of elevated blood pressure(Ofstad and Iversen 2005).
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1.2.3 Acute control of blood pressure: Baroreceptors
BP control mechanisms include concerted effects by multiple organ systems to
maintain adequate blood flow to the entire body. This integrated effort requires the use of
both short- and long-term mechanisms to regulate BP. Short-term, or acute, mechanisms
of BP control are rapid mechanisms that induce changes in blood vessel diameter, heart
rate, or cardiac contractility. Acute mechanisms of BP control include the baroreceptors,
chemoreceptors, and atrial receptors, as well as the integration and response of these
signals in the brain. Long-term, or chronic, mechanisms of BP control are slow-acting
mechanisms that focus primarily on the regulation of blood volume. Chronic mechanisms
of BP control center around the actions of the kidney and natriuresis in response to
changes in BP.
Baroreceptors are spray-type nerve endings found in the arterial walls of the carotid
sinus and the aortic arch (Guyton and Hall 2006). The carotid sinus baroreceptors are
high-pressure mechanoreceptors and are stimulated by pressures above 60 mmHg up to a
maximum stimulation of 180 mmHg. Comparatively, aortic baroreceptors are stimulated
by blood pressures higher than 90 mmHg. Baroreceptors sense increases in arterial
pressure via distention in the arterial wall, which then induces signaling to the nucleus
tractus solitarius (NTS) where interneurons inhibit the sympathetic preganglionic neurons
and excite the parasympathetic neurons. This integrated response causes a decrease in
arterial pressure by two distinct mechanisms: a decrease in heart rate due to stimulation
of the vagus nerve and a decrease in peripheral resistance by lowering sympathetic tone
in the arterial wall. This is clearly demonstrated when a person moves from a supine to
standing position. The act of standing tends to cause a drop in arterial pressure in the
10

head and upper body. This could lead to a loss of consciousness, however, the drop in BP
at the baroreceptor elicits a strong sympathetic discharge to preserve BP in the head and
upper body and prevent fainting from under perfusion of the brain.
While it is well accepted that the baroreceptor reflex is important to short-term
regulation of BP control, some believe that the baroreceptor reflex may also be involved
in the long-term regulation of BP via control of sympathetic nerve activity (SNA)
(DiBona 2004, Guyenet 2006). Studies have shown that unloading of the baroreceptors
by placement of ligature distal to the carotid sinus caused sustained increases in mean
arterial pressure (MAP), heart rate (HR), and plasma renin activity (PRA) while
decreasing urinary sodium excretion(Thrasher 2002). These changes are indicative of
increased renal sympathetic nerve activity in response to a lowered pressure in the carotid
sinus, indicating that the baroreceptors can play a role in the long-term regulation of BP.
Similar to the high-pressure mechanoreceptors in the carotid sinus and aorta, lowpressure baroreceptors in the atria and pulmonary arteries help to regulate BP in the low
pressure sections of the circulation. Increased pressures in these low-pressure areas are
caused by increases in blood volume, so the end effects of these reflexes are geared to
quickly sensing and correcting those increases. The Bainbridge reflex is activated when
the atrial stretch receptors are stimulated. Afferent signals are transmitted via the vagal
nerve to the NTS and travel to the paraventricular nucleus (PVN) to elicit efferent
stimulation of the sympathetic nervous system and inhibition of the vagal nerve to
increase heart rate and contractility(Coote 2005, Guyton and Hall 2006). This reflex
prevents retention of blood in the atria, veins, and pulmonary circulation.
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Activation of the atrial baroreceptors can elicit a volume reducing response in the
kidneys. Excitation of the PVN stimulates GABA-nergic interneurons that synapse and
inhibit the renal sympathetic nerves (Coote 2005). This concomitant excitation of one
arm of the sympathetic nervous system (SNS) while inhibiting other arm of the SNS is
likely due to a hard-wired neuronal network in the PVN that is specifically activated by
activation from the cardiopulmonary reflex(Coote 2005). Inhibition of RSNA induces
dilation of the afferent arterioles in the kidney, increasing glomerular capillary pressure
and glomerular filtration rate (GFR) to increase sodium and fluid excretion. Other signals
from the hypothalamic neurons decrease the secretion of anti-diuretic hormone (ADH),
encouraging natriuresis and volume contraction.
Atrial distention also causes the release of atrial natriuretic peptide (ANP) from the
atrial granules in the heart (Dietz 2005). Once released, ANP travels to the kidneys and
causes minor increases in GFR and decreases Na+ reabsorption in the collecting ducts.
This natriuretic effect helps to decrease volume overload in the circulation. Infusion of
exogenous ANP inhibits the secretion of both renin and aldosterone and inhibits plasma
aldosterone in response to angiotensin II (Chopra, Cherian et al. 2013).

1.2.4 Acute control of blood pressure: Chemoreceptors
Chemoreceptors are another type of sensor found in the arterial wall, however, these
receptors sense changes in oxygen, carbon dioxide and hydrogen ion levels. They reside
in carotid bodies in the common carotid artery and near the aorta. Carotid bodies are
supplied with blood flow via a small nutrient artery. This allows constant contact with the
12

blood supply. Should blood flow fall below critical levels, the diminished flow in the
small artery activates the chemoreceptors to signal to the vasomotor center and stimulate
sympathetic vasoconstriction to increase arterial pressure (Guyton and Hall 2006).
Hypoxemia, hypercapnia, and acidemia all initiate signaling of chemoreceptors.
Chemoreceptor activation also increases ventilation, which combined with SNS
activation can increase blood oxygen content and conserve oxygen use by the
tissues(Dampney, Coleman et al. 2001). However, it’s important to note that the
chemoreceptors are not powerful controllers of BP until pressure falls to <80 mmHg.
Recent attention to the role of the chemoreceptors and the sympathoexcitatory
chemoreflex described above has led to the postulation that removal of the carotid
chemoreceptors may be a viable treatment for hypertensive patients. Studies in the SHR
showed that denervation of carotid bodies attenuated hypertension in animals with both
developing and established hypertension, with no changes in blood pressure in
normotensive animals(Abdala, McBryde et al. 2012). HT patients and patients with
normal blood pressures with a family history of hypertension have increased ventilatory
response to hypoxia, suggestive of an increased chemosympathetic drive that may
contribute to the development of hypertension(Izdebski, Izdebski et al. 2006). In addition,
a few human studies have reported reductions in BP after carotid body removal,
suggesting that carotid body denervation may be future therapeutic tool in the treatment
of hypertension(Paton, Sobotka et al. 2013).
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1.2.5 Chronic control of blood pressure: Pressure natriuresis
Chronic control of blood pressure deals with primarily the regulation of body fluid
volumes via the kidney. The kidney must regulate body fluid homeostasis by ensuring the
balance between fluid intake and output. This seemingly simple task involves the
coordination of multiple nervous system and hormonal signals, as well as local systems
within the kidney itself. Simply, increased extracellular fluid in the body causes fluid
redistribution and an increase in blood volume, which in turn increases the arterial
pressure. When the arterial pressure rises, blood flow through the kidneys increases. This
creates increased filtration through the glomeruli of the kidney and increased filtrate into
the tubule of the nephron. The ultrafiltrate in the tubule moves through the proximal and
distal tubules to the collecting ducts and finally to the bladder, where it is excreted.
Figure 1.1 shows the relationship between intake and renal output of water and
salt and the relationship to arterial pressure. The kidneys strive to operate at the
“equilibrium point” shown here. If body fluid volume and arterial pressure increase, renal
outputs of water and salt will increase. This loss of salt and water will decrease body
fluid volume and arterial pressure until the pressure returns to the equilibrium point.
Should arterial pressure fall below the equilibrium point, the kidneys will retain salt and
water until equilibrium is reached again. This concept is known as the “infinite gain” of
the renal function curve. These mechanisms provide the kidney with the ability to sense
and control arterial pressure in the body. The kidney must be able to sense extracellular
fluid volume as well as respond to renal perfusion pressure. As extracellular fluid volume
is regulated by the concentration of sodium in the body, the kidney utilizes a set of
specialized cells located in the cortical thick ascending limb, known as the macula densa,
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to sense sodium levels. The macula densa resides in the juxtaglomerular apparatus and
can sense tubular flow and NaCl concentration.
Based on this information, there are two major ways to manipulate the long-term
control of body pressure: shifting of the renal output curve or changing the level of the
salt and water intake line. It is important to note that a permanent or long term change in
either of these curves can cause a new equilibrium point to be created – and this point
will act as the new set point for the renal regulation of BP.
This concept demonstrates the importance of salt and water intake to the long-term
regulation of BP. Increased water intake doesn’t affect arterial pressure greatly, as pure
water is normally excreted through the kidneys as rapidly as it is ingested. In contrast,
excess salt intake can greatly influence arterial pressure. As salt is ingested, it enters the
extracellular fluid (ECF) and increases ECF osmolality. Subtle 2-3% changes in the
osmolality can stimulate a thirst response in humans (Stachenfeld 2008), causing
increases in ECF, blood volume, and BP. Increases in osmolality also stimulate the
hypothalamic-posterior pituitary axis to release ADH to stimulate water reabsorption in
the renal tubules. This water reabsorption increases the extracellular fluid volume and
lowers osmolality. The strong influence of sodium intake on control of BP is part of the
reason that hypertensive patients are often encouraged to partake in a low sodium diet.
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1.3 Hormonal regulation of blood pressure
Extrinsic controllers of blood pressure such as hormones are crucial for the body’s
ability to respond to changes in tissue energy needs. Endocrine factors that can affect
blood pressure include, but are not limited to, the renin-angiotensin-aldosterone system
(RAAS),sex hormones such as estradiol and testosterone, atrial natriuretic peptide, and
vasopressin.

1.3.1 Renin-angiotensin-aldosterone system
A key mechanism of chronic BP regulation is the RAAS, a hormonal cascade with
local and systemic effects on body fluid volumes, BP and renal function. Figure 1.2
shows the major classical RAAS pathways as well as pharmacological targets and
associated molecules. The first molecule in the pathway is angiotensinogen, a 453-amino
acid (aa) peptide synthesized by the liver. This a-2 globulin is the classical substrate for
the renin enzyme. Interestingly, other enzymes such as tonin, cathepsin G, and trypsin
have been found to synthesize angiotensin II directly from angiotensinogen (Belova
2000).
Prorenin is synthesized and stored in the juxtaglomerular cells found in the wall of the
afferent arteriole next to the glomerulus. When arterial pressure falls, cellular
mechanisms not well understood cause the cleavage of prorenin into renin and release the
activated form into the circulation (Kurtz 2011). Renin acts upon angiotensinogen to
cleave angiotensin (Ang) I, a 10-aa peptide with slight vasoconstrictor properties that
travels in the systemic circulation. Once Ang I reaches the lungs, angiotensin converting
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enzyme (ACE) cleaves two aa off to form angiotensin II. Other enzymes can perform this
step - chymase, which is produced in mast cells, can also catalyze this reaction.
Ang II is a potent vasoconstrictor with effects in multiple tissues but a short active
half-life. Effects of Ang II are mediated through two unique receptors, angiotensin type 1
receptor (AT1R) and angiotensin type 2 receptor (AT2R). Binding of Ang II to an AT1R
causes vasoconstriction (and thus increases arterial pressure by increasing peripheral
resistance), sodium retention, water retention, suppresses renin release, induces
hypertrophy in cardiomyocytes and smooth muscle, stimulates vascular and myocardial
fibrosis, stimulates superoxide formation, activates the SNS, and increases endothelin
secretion (Zaman, Oparil et al. 2002). AT1Rs are found in vascular smooth muscle, the
adrenal cortex, and the kidney while AT2Rs are expressed in the kidney, uterus, brain,
adrenal medulla, and adrenal cortex (Bonnardeaux, Davies et al. 1994). Binding of Ang II
to the AT2R induces vasodilation, cell differentiation, tissue repair, apoptosis, and antiproliferative effects (Zaman, Oparil et al. 2002).
In the adrenal cortex, Ang II induces the release of the mineralocorticoid aldosterone
into the circulation. Aldosterone, a steroid hormone, acts primarily on receptors in the
distal tubule and cortical collecting ducts to stimulate the reabsorption of sodium and
water from the tubular filtrate. This increases ECF volume, blood volume, and
consequently, arterial pressure. When dysregulated, aldosterone can be pathogenic and
can contribute to the development of cardiovascular and renal through primary
aldosteronism, which is characterized by hypertension with hypokalemia.
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Ang II contributes to the long-term control of BP by directly and indirectly (via
aldosterone) causing salt and water retention in the kidneys. This powerful hormonal
cascade shifts the renal output curve to the right – meaning that a higher arterial pressure
is required to excrete salt and water from the body (Cowley 1992). Ang II is a major
player in increasing BP after it falls in response to rapid hemorrhage. RAAS also allows a
person to ingest large amounts of salt and maintain relatively normal blood pressure. The
increased ECF and blood flow through the kidneys inhibits the secretion of renin leading
to increased renal excretion of water and salt and return of the ECF and BP to the normal
equilibrium point.
Recent interest in the non-classical components of the RAAS has discovered other
biologically active peptides in the pathway that are relevant to blood pressure regulation.
Ang (1-9) can be converted from Ang I through the actions of angiotensin-converting
enxyme 2 (ACE2), found in the endothelium of coronary vessels and renal tubules. Ang
1-9 binds to the AT2R and is important in local renin-angiotensin activity in the heart and
kidney (Donoghue, Hsieh et al. 2000). Ang (1-7) can be converted from Ang I by the
enzymes nephrilysin or thimet oligopeptidase. Ang (1-7) can also be hydrolyzed from
Ang II by ACE2. Ang (1-7) binds to the GPCR Mas, which has vasodilatory and antioxidant effects (Santos, Simoes e Silva et al. 2002). Ang III is metabolized from Ang II
by aminopeptidase A and binds to both the AT1R and AT2R. Ang III is thought to have
similar physiological effects to Ang II, as they utilize the same receptors, but some
research suggests Ang III may have unique effects in the central nervous system
(Yugandhar and Clark 2013). Ang IV is converted from Ang III by aminopeptidase N
and binds to the insulin-regulated aminopeptidase (IRAP)(Vanderheyden 2009). The
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functionality of IRAP in the context of blood pressure regulation is unknown, but it has
been shown to be involved in pro-inflammatory cascades in vascular smooth muscle cells
(Esteban, Ruperez et al. 2005).

1.3.2 Sex hormones
Sexual dimorphism in the prevalence of high blood pressure in human
populations is a well-described phenomenon. Men have higher rates of hypertension
compared to age-matched women until women reach the age of menopause, at which
point women equal or even exceed men in rates of hypertension (Dubey, Oparil et al.
2002). Additionally, in the male spontaneously hypertensive rat (SHR), the pressurenatriuresis curve is blunted and castration attenuates this reduction, providing a strong
case for the role of androgens in the development of elevated blood pressure (Reckelhoff,
Zhang et al. 1998). In addition, administration of testosterone to ovariectomized females
produced a similar pressure-natriuresis relationship to that of the male SHR, suggesting
that testosterone could affect renal function in women post-menopause. Overall, blood
pressure is higher in male SHR, DOCA-salt, and Dahl salt-sensitive rats compared to
female animals (Dubey, Oparil et al. 2002).
Sex hormones may influence arterial blood pressure through a number of
physiological mechanisms, including, but not limited to endothelin-1, catecholamine
synthesis, and activation of the RAAS. Endothelin-1 has been described as the most
potent vasoactive peptide produced by the human body and has vasoconstrictive, prooxidant, pro-inflammatory, and mitogenic effects. Plasma endothelin-1 levels are
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elevated in men compared to women and female-to-male transitioning patients treated
with testosterone have increases in plasma endothelin-1 (Polderman, Stehouwer et al.
1993). Men and male experimental animals have a more potent vasoconstrictor response
to endothelin-1 compared to women and female animals (Tostes, Fortes et al. 2008). In
porcine coronary artery rings, testosterone incubation potentiated the contractile effect of
endothelin-1 while incubation with 17β-estradiol attenuated the contraction (Toeh, Quan
et al. 2000).
There are multiple sex differences in the expression and functional responses to
the classical and non-classical RAAS pathways. Males display elevated expressions of
the components of the classical RAAS pathway while females have greater expression of
the non-classical RAAS pathways (Sullivan 2008). 17β-estradiol has been shown to
promote the production of Ang 1-7, showcasing the possibility of the female hormonal
environment to favor the vasodilatory actions of the RAAS (Brosnihan, Li et al. 1997).
Glomerular binding of AT1R is significantly reduced in female Sprague-Dawley rats
compared to male rats and removal of the ovaries returns glomerular AT1 binding to
levels similar to males (Rogers, Mitchell et al. 2007). In humans, ACE inhibitors are less
effective in conferring cardiovascular benefits in women compared to men, whereas are
angiotensin receptor blockers have been associated with better survival rates in women
but not men (Sullivan 2008).
Together, this evidence provides a strong argument that sex, and sex hormones,
can have significant effects on the regulation of arterial pressure. It is worth noting that
many other systems and pathways, such as inflammation, oxidative stress, and nitric
oxide, have all been identified and implicated in the relationship between hypertension
20

and sex; however, a full review of all of these mechanisms is outside the scope of this
current work.
1.3.3 Other hormones
Atrial natriuretic peptide (ANP) is secreted from the atrial wall of the heart in
response to increased volume in the atrium. ANP has natriuretic effects through
increasing GFR, inhibiting renin secretion and renal sympathetic nerve activity, and
decreasing sodium reabsorption in the distal convoluted tubule and cortical collecting
duct. Together these actions result in a reduction of ECF and blood volume, returning
blood pressure to normal levels(Brenner, Ballerman et al. 1990).
Vasopressin, or antidiuretic hormone, is synthesized in hypothalamic neurons in
response to hyperosmolality. Vasopressin promotes the reabsorption of solute-free water
in the kidney by promoting the transcription and integration of aquaporin channels in the
renal collecting duct cells. It also has mild vasoconstrictive properties to increase arterial
pressure, though it is not thought to be causal in the development of essential
hypertension, as patients with the syndrome of inappropriate antidiuretic hormone
secretion do not develop hypertension (Holt and Haspel 2010).
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1.4 Neural regulation of blood pressure

The kidney auto-regulation theory developed by Guyton (Guyton 1991) has been
a source of controversy for many years, particularly since the theory disregards the
contribution of TPR in the development of hypertension. A major determinate of TPR is
vascular smooth muscle contraction induced by the autonomic nervous system. The
autonomic nervous system is divided into two major arms, the sympathetic and
parasympathetic nervous systems. These two parallel arms consist of cholinergic neurons
that synapse to efferent motor neurons and other peripheral targets. Parasympathetic
neural control of the circulation operates through the parasympathetic neurons that
innervate the heart, while sympathetic control is mediated by efferent neurons that
innervate blood vessels, the adrenal medulla, the kidneys, and the heart (Guyenet 2006).
Anatomical placement of the autonomic nervous system allows it to affect crucial
variables like CO and arterial resistance, strengthening the argument that the autonomic
nervous system is key to the regulation of BP.

1.4.1 Sympathetic nervous system
Neuronal networks in the rostral ventrolateral medulla, spinal cord, hypothalamus,
and NTS control sympathetic outflow. Sympathetic nerve activity is stimulated through
signals from baroreceptors, chemoreceptors, and afferent sensory nerves from organs
such as the kidney, heart, and vasculature. After integration and processing in the central
nervous system, the efferent motor neurons transmit signals to the appropriate tissues and
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organ systems. The majority of these efferent motor neurons are adrenergic, utilizing
catecholamines as the primary neurotransmitter. Catecholamines, such as norepinephrine
(NE) and epinephrine (E), bind strongly to a class of receptors known as the adrenergic
receptors, a group of G-protein coupled receptors (GPCRS). Adrenergic receptors are
categorized in two major groups, α- and β- adrenoreceptors, and further divided into
various subtypes, the α1-, α2-, β1-, β2-, and β3- adrenoreceptors. In addition, subtypes of
the α1- and α2- classes have been identified as the α1A-, α1B-, and α1D-adrenoreceptors,
and the α2A-, α2B-, and α2C- adrenoreceptors, respectively. As GPCRs, ligand binding
to adrenoreceptors initiates a cascade of downstream signaling events that involve the Gproteins, however, each class of receptors has distinct intracellular pathways. α1adrenoreceptors utilize the Gq pathway, activating phospholipase C to increase
intracellular calcium and signal the activation of protein kinase C. α2-adrenergic
receptors initiate the signaling of the Gi protein, which inhibits adenylyl cyclase and
activates inwardly rectifying potassium channels attached to G-protein coupled receptors.
β-adrenergic receptors stimulate the Gs pathway, which activates adenylyl cyclase to
produce cyclic adenosine monophosphate (cAMP). Increases in intracellular cAMP
activate the cAMP-dependent kinase, protein kinase A.
While adrenergic receptors are clearly important to the effector arm of the
sympathetic nervous system, reports of peripheral adrenergic receptor numbers in
experimental models of hypertension vary greatly (Michel, Brodde et al. 1990). However,
the effectiveness of sympatholytic drugs, such as α- and β- adrenergic receptor blockers,
in the treatment of hypertension suggests a sympathetic component to the development
and/or maintenance of hypertension. Patients with essential hypertension, particularly
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younger patients, have increased sympathetic outflow and NE spillover to the heart,
kidney, and skeletal muscle vasculature (Esler 2000). However, markers such as systemic
plasma NE are not strongly correlated with hypertension, suggesting that specific
regional sympathetic activation is more important to the development of hypertension
than general increased sympathetic outflow(Esler 2000).

1.4.2 Renal sympathetic nerve activity
The efferent renal nerves innervate the kidney in association with the renal artery
and vein. The nerves terminate in vascular and tubular structures throughout the kidney,
including the interlobar, arcuate, and interlobular arteries; the afferent and efferent
arterioles; nephron segments, such as the proximal tubule, loop of Henle, distal
convoluted tubule, cortical collecting duct; and juxtaglomerular apparatus (DiBona and
Kopp 1997, Johns and Abdulla 2013). Efferent renal nerves are postganglionic and the
majority of them are adrenergic, releasing NE from their terminals.
Differential distribution of each of the adrenergic receptor subtypes within the
kidney has major effects on renal function. α1-adrenergic receptors are found mainly in
the renal cortex and outer medulla and mediate both vascular and tubular responses to
sympathetic activation. α1A-adrenoreceptors are the major mediator of the
vasoconstrictor response to NE, as α1A- activation causes constriction of the afferent and
efferent arteriole, which reduces both renal blood flow and glomerular filtration rate
(DiBona and Kopp 1997). α1B- and α1D-adrenergic receptors are also located on
vascular smooth muscle, albeit in lower densities than α1A adrenoreceptors
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(Salomonsson, Oker et al. 2001). α1B-adrenoceptors are highly expressed in the inner
medulla on tubular cells and mediate sodium and water reabsorption (Elhawary and Pang
1994). α2- adrenoreceptors are primarily expressed in vasculature and involved in
vasoconstriction (Civantos Calzada and Aleixandre de Artinano 2001). β1-adrenergic
receptors are found in the granular cells of the afferent arteriole and mediate the secretion
of renin elicited by renal nerve activation (Osborn, DiBona et al. 1981). β2-adrenergic
receptors are expressed mainly in medullary tubules and regulate sodium transport
(Healy, Munzel et al. 1985, Singh and Linas 1996). β3-adrenoceptors are located in thick
ascending limb, thick ascending limb, distal convoluted tubule and cortical collecting
duct of the kidney. Recent research in mice suggests that tubular β3-adrenoceptors may
have an antidiuretic effect when stimulated (Procino, Carmosino et al. 2016).
Much of the evidence supporting the contribution of renal sympathetic nerve
activity to the development of hypertension has arisen from renal denervation studies in
experimental models and patient populations. Renal denervation, ablation of the renal
nerves, was shown to delay the progression of hypertension or lower blood pressure in
many experimental models, including the Dahl salt-sensitive rat (Foss, Fink et al. 2013),
the spontaneously hypertensive rat (Norman Jr and Dzielak 1982), DOCA-salt model of
hypertension (Jacob, Clark et al. 2005), and angiotensin II induced hypertension in rats
(Hendel and Collister 2006). Work from John W. Osborn’s group has identified the
specific ablation of renal afferent nerves in multiple experimental models of hypertension
as a key component to successful reduction in BP in denervation studies(Foss, Wainford
et al. 2015). Early studies showed translational success with renal denervation in resistant
hypertensive patients (Krum, Schlaich et al. 2009, Symplicity, Esler et al. 2010). It is
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worth noting that the results from catheter-based renal denervation studies have been
controversial. Some studies have reported lowered blood pressures (Townsend, Mahfoud
et al. 2017) while others have found no significant differences in patient blood pressures
(Bakris, Townsend et al. 2014, Bhatt, Kandzari et al. 2014). Renal denervation trials in
human patients are still ongoing and controversial(DiBona and Esler 2010).
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1.5 Chlorocebus aethiops sabaeus, the African Green Monkey
Hypertension affects approximately one in three adults in the United States and is
a major modifiable risk factor for the development of cardiovascular disease, stroke, and
chronic kidney disease. While major strides in the treatment of hypertension have been
made in the last 60 years, a remarkable 13% of patients in the United States still suffer
from resistant hypertension, defined as uncontrolled blood pressure while on three or
more classes of anti-hypertensive medications (Persell 2011). This treatment gap suggests
that new, novel models need to be investigated to determine the etiology of essential
hypertension. While rodent models have contributed greatly to our understanding of
regulation and dysregulation of blood pressure, key differences between humans and
rodents may hinder the translational capacity of treatments developed primarily in those
models. The research continued in this doctoral thesis focuses on the characterization of
a non-human primate model of spontaneous hypertension that may be uniquely suited to
help bridge the translational treatment gap in hypertension research and medicine.

1.5.1 Phylogeny and history
The African green monkey (AGM) is an Old World Monkey belonging to the
genus Chlorocebus. The Chlorocebus genus is estimated to have diverged from human
lineage approximately 23 million years ago (Jasinska, Schmitt et al. 2013). There are
multiple recognized subspecies of the AGM, which are phenotypically distinct and
thought to have diverged approximately 600,000 years ago from each other (Pfeifer
2017). The six subspecies include: aethiops, cynosuros, hilgerti, pygerythrus, sabaeus,
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and tantalus, and each are geographically isolated, though significant admixture occurs
between subspecies (Svardal, Jasinska et al. 2017).
The AGM is native to Africa and is highly adaptable, occupying nearly every
ecosystem in Africa from swamps to savannahs to mountainside slopes (Palmour,
Mulligan et al. 1997). AGMs were introduced to the Caribbean islands of St. Kitts, Nevis,
and Barbados during the colonial era. It is thought that they were bought from West
Africa as pets with the shipping industry(Van Der Kuyl, Dekker et al. 1996) and once
introduced, quickly became an invasive species (Jasinska, Schmitt et al. 2013). By the
late 1700s, the monkeys had become a large pest species. One account, attributed to Lady
Andrews who was visiting from England in 1774, suggests that the AGM population
tormented visitors and locals alike.
“Their frolics are mischievous, their thefts dexterous. They are subtle enemies and false
friends. When pursued they fly to the mountain and laugh at their pursuers, as they are
little ashamed of a defeat as a French admiral or general. In short, they are the torment
of planters; they destroy whole cane pieces in a few hours and come in troops from the
mountain, whose trees afford them shelter. No methods [sic] to get the better of them has
yet been found out.” (Ervin 1993)
Currently, the Caribbean AGM population is estimated to number between 50,000
to 100,000 individuals (Jasinska, Lin et al. 2012). Recent genome-wide analysis work by
Svardal and colleagues has found that the St. Kitts AGM population was founded by C.
sabaeus animals found in the Gambian region of West Africa (Svardal, Jasinska et al.
2017). Meanwhile, the Nevis population of animals was descended from St. Kitts derived
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animals, as identified by the decrease in genetic diversity, while animals on nearby
Barbados were derived from a separate introduction of Gambian vervets. Thus, the St.
Kitts vervet population consists of a bottleneck population descended from animals in the
Gambian region of West Africa, making it a novel population in which to study genetic
diversity, disease, and environmental adaptation.

1.5.2 Behavior and reproduction
The average lifespan of the AGM is approximately 10-12 years of age in wild due
to high levels of predation and limitations on food/water (Isbell, Young et al. 2009).
However, in captivity, there have been reports of AGMs surviving upwards of 25 years of
age (Schmitt, Service et al. 2017). Male animals typically weigh 5-6 kilograms in
adulthood, while adult females are slightly smaller, averaging 3-4 kilograms. AGMs are
omnivorous, but prefer to eat fruit or flowers when available (Harrison 1983).
Observational studies have shown that AGMs tend to first feed early in the morning and
again in the late afternoon. Inactivity and grooming, an important social behavior,
typically occurs in the middle of the day, when temperatures peak (Baldellou and Adan
1998).
AGMs have unique social structures and participate in complex behaviors like
parenting, cooperation, and significant territoriality in both the wild and captivity. Their
social structure is female philopatric, wherein females remain with their natal troop and
males typically disperse after they reach sexual maturity. Troops have been reported to be
as large as 75 members in the wild (McGuire 1974) and are typically multi-male and
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multi-female. Within a troop, female siblings and relatives often share parenting
responsibilities of young infants (Fairbanks 1990). Compared to other primates, AGMs
have been observed exhibiting cooperation and altruism with non-kin individuals,
particularly if those individuals have interacted positively with them in the past (Seyfarth
and Cheney 1984).
Menstrual cycles last approximately 29-30 days, similar to both humans and
rhesus macaques (Kundu, May et al. 2013). The follicular phase, lasting from the onset of
the menstruation through the gonadotropin surge, typically lasts 12 days and is
characterized by elevation of follicle-stimulating hormone (FSH) and late (~ day 8)
increases in estradiol which peak simultaneously with the luteinizing hormone (LH) and
FSH surge. The luteal phase, which begins after the gonadotropin surge and ends at onset
of the next menstruation, lasts approximately 16 days and displays increasing levels of
progesterone and low to undetectable levels of FSH, LH, and estradiol (Molskness, Hess
et al. 2007). Similar to humans, the pituitary gonadotropin (LH and FSH) surge mid-cycle
signals the transition from the follicular to luteal phase and promotes oocyte maturation,
ovulation, and development of the corpus luteum.
Reproductive senescence (menopause) is highly relevant to women’s health and
risk of disease in humans. Female AGMs undergo some form of reproductive senescence
as they age, with estimates of reproductive life ending around 20 years of age. Atkins et
al found that serum anti-Müllerian hormone, follicule number, and fecundity were
negatively correlated with age while cycle length and probability of menses cessation
both increased with age (Atkins, Willson et al. 2014).
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Female AGMs can reproduce as early as 3 years of age, but the majority have
their first offspring around 4 years of age (Fairbanks and McGuire 1986). Gestation in the
AGM lasts between 163 and 165 days in captivity. Fecundity is increased in females who
live with their mother compared to females who did not live in the same troop as their
mother, suggesting that mothers provide social support long after their female progeny
have reached adulthood, which in turns relates directly to reproductive and social success
(Fairbanks and McGuire 1986). In Africa, vervets exhibit distinct seasonality in birthing,
typically giving birth early in the year between January and March (Dunbar 1974).
However, in captivity, this seasonality largely disappears (Kushner, Kraft-Schreyer et al.
1982).
Of particular interest is the evolution of concealed ovulation in the female AGM
population. Like humans, female AGMs show no outward signs of sexual receptivity or
ovulation. Comparatively, other primate species can show obvious outward signals of
ovulation such as swelling of the perineum or overt behavioral signals like head shudders
or grimaces (Andelman 1987). Andelman postulates that the lack of outward signals of
ovulation in females decreases male-male competition and reduces the probability of
infanticide in multi-male troops in the wild. In addition, phylogenetic analysis of
concealed ovulation in multiple primate species similarly suggests that the evolution of
this trait may promote positive male behavior toward offspring due to parental confusion
(Sillen-Tulberg and Moller 1993).
Male reproductive success in the AGM is largely determined by dominance rank.
In one study of captive AGMs, the highest ranked male, based on behavioral
observational data collected in a 3.5 year period, had more reproductive success than
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subordinate males in the first mating season. However, as the study progressed,
reproductive success actually decreased for the alpha male as his tenure increased (siring
100% of offspring in the first mating season and only 56% of offspring in the third). By
the fourth season, a younger male, who then sired all offspring born by the conclusion of
the study, replaced the alpha male (Weingrill, Willems et al. 2010). The authors attribute
this to either increased competition between the males or female preference for younger
males. Steklis et al found that plasma testosterone was not correlated to dominance rank,
though it was associated with initiation of aggressive behavior in dominant, but not
subordinate, males (Steklis, Brammer et al. 1985). Together this suggests that while
plasma testosterone does not directly relate to dominance ranking, it may influence
behavior and thus reproductive success in males, though future studies will be required to
address this exact relationship.
1.5.3 Use as a biomedical model
Non-human primate models are important and essential tools for the biomedical
research community. As a group, NHPs have much greater levels of conservation with
humans at multiple levels of biology in comparison to rodent and murine models. NHPs
are diurnal and have gene sequences and gene structures that are highly similar to
humans. NHPs can also be employed in longitudinal or invasive studies that are not
suitable or infeasible for human research. Primate research has led to critical health
advances in cancer, obesity, AIDS, and Alzheimer’s research (Research 2016). In short,
primate research is critical for continued improvements in the health and lives of people
all over the globe. Knowledge of how primates express and display common, complex
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disease states will not only improve treatment and care, but may provide important
insights into the etiology and development of pathologies.
AGMs are widely used as biomedical models in the fields of virology,
immunology, neurology, and physiology. A PubMed search reveals over 14,500 citations
for the AGM in the last decade, compared to 10,000 for the rhesus macaque, an
endangered but widely utilized NHP in biomedical research. While the AGM is similar to
the rhesus macaque in both physiology and behavior, the AGM is less expensive, more
accessible, and poses fewer health and safety risks due to its disease-free status (Jasinska,
Schmitt et al. 2013). Due to the concerted efforts of the International Vervet Genome
Consortium, an annotated reference genome for the AGM was published in 2015
(Warren, Jasinska et al. 2015) and genetic analysis tools are becoming more widely
available for the species (Huang, Ramensky et al. 2015). AGMs have a higher
chromosome number (n=30) and their genome has undergone 12 rearrangements
compared to the human genome. Extensive synteny with the human genome has been
found, with nine human chromosomes displaying full colinearity with AGM
chromosomes (Jasinska, Service et al. 2007).
The Chlorocebus genus, like many animals of African origin, acts as a natural
host for the simian immunodeficiency virus (SIV) and vervets likely have interacted with
the lentivirus for thousands of years (Worobey, Telfer et al. 2010). Natural hosts, when
infected with SIV, do not progress to immunodeficiency; instead they retain healthy
amounts of CD4+ T cells and low immune activation, despite significant viremia.
Caribbean AGMs are naturally SIV-free, however, once infected, they do not progress to
immunodeficiency and their virological and immunological profiles are very similar to
33

African-born AGMs infected with SIV (Pandrea, Apetrei et al. 2006). This makes the
AGM, in particular the Caribbean AGM, uniquely suited to studying the progression of
SIV in a natural host and may provide insights into the pathology of the closely related
human immunodeficiency virus.
The high level of similarity between the AGM brain and the human brain has led
to the use of the AGM in studies of neurobiology and neurodegeneration. AGMs (greater
than 20 years of age) develop amyloid-β plaques in the frontal and temporal cortex that
are associated with gliosis and neuritic dystrophy. Immunization with amyloid β in aged
animals successfully decreased cortical plaque formation and has been proposed as
possible treatment against Alzheimer’s disease (Lemere, Beierschmitt et al. 2004).
Genetic linkage analysis of amyloid β markers in the cerebral spinal fluid of aged AGMs
has recently identified loci on vervet chromosomes 4 and 12 that may mediate
neurodegenerative changes (Chen, Fears et al. 2018).
AGMs, like many Old World monkeys, can develop atherosclerosis, insulin
resistance, and obesity when fed a typical Western diet and longitudinal studies have
shown that these factors are heritable in the species (Kavanagh, Fairbanks et al. 2007,
Schmitt, Service et al. 2017). Genetic analysis of obesity in the AGM reveals, that similar
to human, obesity and obesogenic growth are likely complex, polygenic traits with both
genetic and environmental influences. While other models exist to study these
multifactorial interactions, the AGM is unique in that investigators can experimentally
manipulate all of these variables in a highly translational model organism.

34

Elevated blood pressures in the African Green Monkey were first reported by
Kraft-Schreyer and Angelakos in the 1980s (Kraft-Schreyer and Angelakos 1985).
Angelakos attempted to create a strain of AGMs that would inherit spontaneous
hypertension by breeding animals with normal and elevated blood pressures (Kushner,
Kraft-Schreyer et al. 1982). First generation offspring with two HT parents had
significantly elevated mean blood pressures compared to offspring born from NT
parentage. In addition, blood pressure increased in all F1 animals with age, however, HT
offspring had the greatest slope of any group(Kraft-Schreyer, Kushner et al. 1987). This
suggested a larger contribution of age to elevation of blood pressure that was dependent
on genetic factors in the AGM. Angelakos speculated that a HT strain of the AGM could
be developed through selective breeding and showed significant differences in blood
pressure distributions in offspring as early as the first generation (Kraft-Schreyer,
Kushner et al. 1991).
Once described, research scientists began to utilize AGMs in experimental studies
involving blood pressure regulation. Pavel Hamet reported that both acute and chronic
infusion of atrial natriuretic factor, a diuretic, natriuretic, and vasoactive peptide, lowered
blood pressure in HT(Hamet, Tremblay et al. 1986) and NT monkeys (Hamet, Testaert et
al. 1989). Frank Ervin’s group published an initial characterization of spontaneous
hypertension in adult male AGMs, showing that acute administration of captopril (4
mg/kg), an ACE inhibitor, significantly lowered blood pressure in HT, but not NT,
animals. Infusion of furosemide (3.5 mg/kg), a loop diuretic, had no effect on blood
pressure in either NT or HT AGMs (Martin, Palmour et al. 1990).
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Blood pressure in the AGM was shown to be salt-sensitive in studies by
Srinivasan et al. Adult male AGMs were exposed to graded increases of dietary sodium,
0%, 3%, 4.5%, and 6% NaCl diets for 45, 139, 37, and 90 days, respectively. Body
weight did not differ between any of the diets, but mean systolic and diastolic pressures
were elevated as NaCl intake increased (Srinivasan, Dalferes et al. 1984).
Together this data support the development of the AGM as a model of
spontaneous hypertension and associated cardiovascular and kidney diseases. This
doctoral thesis will expand upon the body of research available and attempt to determine
probable mechanisms crucial to the development and maintenance of hypertension in this
specific animal model.
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1.6 Rationale, overall hypothesis, and specific aims

The development of highly translational models is crucial to innovative and
groundbreaking research. In addition, the ability to assess and examine spontaneously
occurring disease pathologies in a closely related species presents a unique opportunity
for researchers to study and determine etiology of complex diseases like hypertension.
The overall hypothesis of this doctoral thesis is that the African Green Monkey develops
spontaneous hypertension with strong translational parallels to human hypertension and
provides a novel model to study the etiology of hypertension and its related pathologies.
In service of this hypothesis, the following specific aims were examined:

Specific Aim 1: To determine the prevalence of hypertension in a research colony
comprised of wild-caught African Green Monkeys and to examine pathologies in cardiac
and renal tissues crucial to the regulation of blood pressure.

Specific Aim 2: To assess the interaction between elevated blood pressures and sex in
renal function, with a particular focus on glomerular filtration rates, and urinary excretion
of protein, sodium, and potassium in African Green Monkeys.

Specific Aim 3: To determine the effect of the sympathetic nervous system on
hypertension in the African Green Monkey
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Specific Aim 4: To elucidate the effect of age on the development of elevated blood
pressure and renal function in the African Green Monkey
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Figure 1.1 The renal function curve
The renal function curve, adapted from Guyton and Hall, 2006
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Figure 1.2 The classical renin-angiotensin-aldosterone system
The renin-angiotensin-aldosterone system, adapted from Zaman, Oparil et al. 2002.
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2.1 Introduction
An estimated 78 million adults in the United States suffer from hypertension, a major
risk factor for cardiovascular disease and stroke (Go, Mozaffarian et al. 2014). In the vast
majority of these adults (90%), the cause of the elevated blood pressure is unknown, or
“essential”. In addition, 6.1 million Americans suffer from resistant hypertension, or
uncontrolled blood pressure while prescribed ≥ 4 anti-hypertension medications(Persell
2011). Elevated blood pressure, left ventricular hypertrophy, cardiovascular disease, and
end stage renal disease contribute to one out of every three deaths(Go, Mozaffarian et al.
2014) in western developed nations. Though many different pharmacological therapies
have been developed over the past 50 years (with varying degrees of effectiveness), the
significant proportion of hypertensive patients with unknown etiology and resistance to
currently available medication, might suggest that more translational animal models are
needed for the discovery of novel therapies and drug targets.
Current experimental models of hypertension can lack the translational capability
required to closely mimic the complex behavioral, physiological, and pathological
characteristics of human essential hypertension. Differences between experimental and
genetic animal models of hypertension and human essential hypertension can include a
lack of upright posture, different circadian rhythms, disparate or undefined social
structure and hierarchy, genetic diversity, and unique evolutionary histories. These major
differences in fundamental behavioral parameters can undermine the ability of
cardiovascular researchers to address the basic etiology of human essential hypertension.
Thus, there remains a critical need for an animal model that equates to the human
pathophysiology of hypertensive disease allowing the identification of fundamental
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causal relationships and the translation of therapies for the treatment and long-term
prevention of hypertension.
Chlorocebus aethiops sabaeus, the African Green monkey (AGM) is a novel
nonhuman primate model of spontaneous hypertension. Commonly known as the vervet,
this species was derived from founder populations of AGMs in Western Africa and is
currently thriving as an invasive species within specific islands in the West
Indies(McGuire 1974, Van Der Kuyl, Dekker et al. 1996). The AGM behaviorally and
socially equates to humans since they live within troops containing a well-described
social structure and hierarchy(Dunbar 1974). They are a diurnal species with large
syntenic chromosomal regions when compared with humans(Palmour, Mulligan et al.
1997, Jasinska, Schmitt et al. 2013) and exhibit complex social behaviors including
male/female parenting of offspring, individual and group cooperation within troops, and
significant territoriality in both the wild and captivity. In captivity, these primates can
survive to approximately 25 to 35 years old(Shively, Willard et al. 2012) and have been
used as biomedical models in the study of neurodegenerative disorders, fetal alcohol
syndrome, simian immunodeficiency virus, diabetes, obesity, and many other complex
pathologies and behaviors (Palmour, Mulligan et al. 1997, Jasinska, Schmitt et al. 2013).
While there are numerous models of experimentally induced hypertension in various
primate species ranging from baboons to rhesus macaques (Cody, Rodger et al. 1982,
Jannetta, Segal et al. 1985), the Caribbean vervet develops spontaneous hypertension in
the wild and in captivity without specialized breeding or dietary intervention. Goldwater
et al. first identified elevated blood pressures in individual Caribbean vervets over 30
years ago(Hamet, Tremblay et al. 1986). We now report the existence of significant,
43

spontaneously occurring hypertension in Chlorocebus aethiops sabaeus in a large cohort
of phenotyped animals with the potentially confounding consequences of the
hypertension in the development of altered renal vascular and glomerular morphology.
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2.2 Methods
2.2.1 Animal care and housing

Animals were housed in troop enclosures at an outdoor facility in St. Kitts, West
Indies. All protocols strictly adhered to the Guide on the Care and Use of Experimental
Animals, Guiding Principles on the Care and Use of Experimental Animals by the
American Physiological Society. Water was allowed ad libitum. All animals were fed
nonhuman primate chow 3 days per week (Harlan, Teklad 8773) and a combination of
fresh bananas, mangos, carrots and sweet potatoes the other 4 days per week. All animals
were individually quarantined for a minimum of 30 days and undergo a full veterinary
examination prior to any handling or introduction into the colony troops. Females born
into a troop remain with their natal troop until reaching sexual maturity at which time
they may remain or be introduced into another troop society group. Males remain with
their natal troop until adolescence and are then introduced into a new troop after reaching
sexual maturity.

2.2.2 Measurement of blood pressures

Animals were lightly sedated with ketamine (15 mg/kg i.m.). All equipment was
thoroughly cleaned between animals to eliminate any foreign scent. After ~10 minutes,
animals were placed in a supine position on a clean examination table and a newborn or
infant blood pressure cuff placed on the left upper arm. The choice of cuff size was
determined based upon the upper forearm diameter to assure accuracy of blood pressure
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measurements. Cuff pressure was measured using a digital pressure gauge (Vernier
Systems, Inc.) and a Doppler stethoscope to identify forearm vascular flows. The blood
pressure technique was developed as an adaptation of the recording techniques previously
reported for rodents and utilized extensively in our lab(Collett, Hart et al. 2013). The
cuff was inflated to a pressure that achieved full radial artery occlusion. Traditional
forearm Korotkoff sounds indicative of systolic (Korotkoff sound 1) and diastolic
(Korotkoff sound 2) blood pressures were identified as the blood pressure cuff slowly
deflated. This process was repeated until 5 arterial systolic and diastolic pressure
measurements were recorded within less than 5% deviation for each animal with
approximately 30-second full deflation times between each consecutive measurement.
After blood pressure was recorded, heart rate was measured by simply counting pulsatile
beats for 15 or 30 seconds. Each animal was weighed and provided an abbreviated health
assessment before being placed back within its’ respective enclosure. When available,
age was determined from the animal’s complete long-term medical records. Both systolic
and diastolic pressures were obtained and recorded for each animal, but only systolic
pressures were used for determination of each individual animal’s specific phenotype.
Forearm cuff plesythmography systolic measurements were verified by both direct
arterial catheter measurement (n=2) and radiotelemetry (n=4) on separate animals
(Supplemental Figure 1).
Characterizations of blood pressures of sexually mature, adult vervets (n=424) were
organized into three groups, based upon systolic blood pressure (SBP) values. SBP was
utilized since this pressure provides the most consistent measurement (i.e. least amount of
intra-animal variance) within any given individual using forearm plethysmography due to
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the clear identification of Korotkoff sound 1. Animals with a SBP ≥ 140mmHg were
categorized as hypertensive (HT), while animals with SBP ≤ 120mmHg were considered
normotensive (NT). Individuals with SBPs of 121 – 139 mmHg were classified as
borderline hypertensive (BHT). Mean arterial pressure (MAP) was calculated as 1/3 SBP
+ 2/3 DBP.
After blood pressure measurements, selected animals were fully anesthetized with
supplemental ketamine (25 mg/kg, i.m.) and xylazine (100 mg/kg i.m.). Anesthetized
animals were then euthanized with an overdose of sodium pentobarbital (ButhenasiaR;
150 mg/kg, i.v.). Tissues were then harvested and thinly sliced for tissue fixation or
immediately frozen in ultra-cold isopentane (-20 0C) and dry ice.

2.2.3 Quantitative real-time polymerase chain reaction

Flash-frozen kidney and liver tissue was dissected from animals and transported
to Lexington, KY on ice. RNA was extracted using Direct-zol RNA kits (Zymo Research,
Irvine, CA) and converted to cDNA using qScript cDNA SuperMix (Quanta BioSciences,
Gaithersburg, MD). qPCR was performed using the StepOnePlus Real-Time PCR System
(Thermo Fisher Scientific, Waltham, MA) with Power SYBR Green (Thermo Fisher
Scientific, Waltham, MA). Relative gene expression was calculated using the 2-ΔΔCT
method(Livak and Schmittgen 2001). Primers for angiotensinogen were custom designed
using Primer3 software (Forward primer 5’-AAGATTGGCAGCCCCCTGAC ; Reverse
primer 5’-ATCTTCCCTTGGAAATGGACGTAG )
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2.2.4 Renal cortical renin content

Renal renin content was determined by measuring the Ang I generation capacity of
homogenized renal cortical tissue. After removal from the animal during autopsy,
kidneys were flash frozen and stored at -20°C. Cortical sections were dissected out on
ice, blotted and weighed, homogenized in buffer, and centrifuged for 20 minutes at 2000
rpm. The supernatant was removed and diluted with MEM buffer at 1:50 ratio. Aliquots
(5 μL) were again diluted at 1:20 ratio in buffer. Aliquots of 200 μL peptidase inhibitor
(3% PMSF in methanol and 3.8% EDTA, pH 6.5) and 200 μL sheep angiotensinogen
(500 ng) were added, the entire mixture was incubated at 37°C for 30 minutes. Samples
were placed on ice and 500 μL of 0.015M HCl added to terminate the reaction. Tubes
were boiled for 10 minutes and then centrifuged. Supernatant was removed and the
generated Ang 1 was measured by radioimmunoassay, as previously described(Haber,
Koerner et al. 1969).

2.2.5 Plasma renin activity

Plasma was collected from sedated animals for determination of PRA.
Ethylenediaminetetraacetic acid was used as the anticoagulant and blood was collected in
chilled tubes. PRA was analyzed by generation of Ang I/h/min using the Gamma Coat
RIA kit (DiaSorin, Stillwater, MN) as previously described and according to the
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manufacturer’s instructions(Atchison, Ortiz-Capisano et al. 2010, Atchison, Harding et
al. 2011).

2.2.6 Tissue histological preparation

For fixation, tissues were sliced into segments 3 cm in length and 3-5 mm thick.
Tissue slices were placed into 5% paraformaldehyde (PFA) for 72 hours (4 0C) with the
PFA changed at 24-hour intervals. The tissues then were placed in phosphate buffered
saline for shipping. All fixed tissues were placed in 70% ethanol for long-term storage.
Histological sections (4 mm thickness) were dissected from tissue slices and prepared
for tissue sectioning using the Histos 5 rapid microwave tissue histoprocessor (Milestone
Medical, Kalamazoo, MI) with the manufacturer’s recommended protocols. After
processing, tissues were embedded into paraffin blocks, cut into 5μm sections using a
microtome, and placed on glass microscope slides. Digital images of sections were
analyzed using Image J software (NIH, Bethesda, MD)(Schneider, Rasband et al. 2012).

2.2.7 Digital analysis of tissue sections

Kidney tissues were sectioned sagittally (5 µm) and stained with Periodic Acid Schiff
stain. Glomeruli and blood vessels in the renal outer cortex were identified (400x) using
an Olympus IX70 inverted microscope and digital images captured and then blinded for
phenotype using a coded numbering system. A minimum of 10 glomeruli from each
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animal were individually traced and isolated within Image J. Using Image J’s automated
thresholding function, the Bowman’s capsular space within the glomeruli is identified
and quantified, resulting in a total area and percent area measurement of space within an
individual glomerulus.
Vascular wall thicknesses were determined for renal vessels with diameters between
100 and 200 m. At minimum, six unique vessels were identified within the renal cortex
of each animal. Digital images of the renal arterioles were captured and assigned a
random number for blinded analysis. Wall thickness and lumen diameters were measured
on 5 different axes around each arteriole. Wall thickness and lumen diameters were
averaged for each arteriole examined, decoded and averaged per animal. Wall/lumen
ratios were calculated for comparisons between NT and HT animals.
2.2.8 Statistical analysis
Groups were compared using a one-way analysis of variance (ANOVA) with a
Tukey’s post hoc comparison. In the case of two group comparisons, an unpaired
Student’s t-test and t-statistic or a Mann-Whitney U test were utilized. All values are
reported as the mean ± standard error of the mean (SEM). The 5% probability level
(p<0.05) was used as the criterion of significance.
Kernel density plots were generated using R 3.0.2 using Bioconductor(Gentleman, Carey
et al. 2004). Kernel density plots estimated the probability of the relationship between
age and blood pressure.
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2.3 Results
2.3.1 Blood Pressure is Elevated in 37% of Adult African Green Monkeys

In a group of 424 adult animals, 44% (187/424) were identified as NT (average SBP=
99.6±1.0 mmHg), 18% (80/424) as BHT (average SBP=130.6± 0.6 mmHg), and 37%
(157/424) as HT (average SBP= 172.0±2.2 mmHg; Figure 2.1). HT animals also have
greater diastolic blood pressure (DBP; 56.2±1.2 vs. 83.1±1.9 mmHg, p<0.05, ANOVA
with Tukey’s post hoc comparison) and consequently calculated mean blood pressure
(MBP; 70.8±1.0 vs. 112.2±1.7 mmHg, p<0.05, ANOVA with Tukey’s post hoc
comparison) compared to NT animals. BHT animals averaged 68.7±2.2 mmHg and
89.4±1.5 mmHg for DBP and MBP, respectively (Figure 2.1).

2.3.2 Heart Rates are Elevated in Hypertensive and Borderline Hypertensive Animals
Heart rate of HT animals averaged 137.7±2.2 beats per minute (BPM) which was
greater than that of NT animals (125.7±2.0 BPM; p<0.05, ANOVA with Tukey’s post
hoc comparison). Heart rates of BHT animals averaged 138.2±3.1 BPM and are
significantly higher compared to NT animals(p<0.05, ANOVA with Tukey’s post hoc
comparison ,Figure 2.2). Heart rates are greater in female animals, regardless of blood
pressure phenotype (males: 124.4±1.3 BPM vs. females: 154.1±2.8 BPM, Figure 2.2B &
2.2C).
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2.3.3 Hypertensive Animals are Older than Normotensive Controls
HT animals were older than NT animals (HT = 12.4±0.7 years; n=52 and NT = 8.9±
0.6 years; n=42, p<0.05; Figure 3A). BHT animals were 11.00±0.9 years old (n=32) on
average, which was similar to both NT and HT animals (p>0.05, ANOVA with Tukey’s
post hoc, Figure 2.3A).
Male and female AGMs have similar incidences of hypertension in adulthood (Male:
119/307 or 38.8%; Female: 38/117or 32.5%). Systolic, diastolic, and mean blood
pressures are similar between male and female AGMs (Table 2.1). Heart rate is
significantly higher in females in all three blood pressure groups (p<0.05, Tukey’s post
hoc).

2.3.4 Components of the Renin-Angiotensin System are Similar in Normotensive and
Hypertensive Groups

Comparative qPCR assessed the gene expression of angiotensinogen in the renal
cortex, outer medulla and liver of adult male AGMs. Angiotensinogen gene expression
was not different between NT (n=17) and HT (n=14) animals in any of the regional
kidney tissues (p>0.05, Student’s t-test, Figure 2.4A). Renal cortical renin content also
was similar between NT and HT animals (p>0.05, Student’s t-test). NT (n=11) animals
RCRC averaged 8.94±1.56 μg Ang II/ml/hr/mg protein while HT (n=13) animals RCRC
averaged 10.73±2.98 μg Ang II/ml/hr/mg protein (Figure 2.4B). Plasma renin activity
also was similar in NT (3.27±0.36 ng Ang I/ml/hr, n=15) and HT (3.34±0.48 ng Ang
I/ml/hr, n=16) animals (p>0.05, Figure 2.4C).
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2.3.5 Renal Vascular Hypertrophy and Wall/Lumen Ratios are Larger in Hypertensive
Animals

Renal vascular hypertrophy was evaluated by measuring the adventitial wall thickness
of renal vessels in male AGMs. HT animals have larger wall thickness compared to NT
animals (14.41 ± 0.56 μm vs. 10.33±1.27 μm, p<0.05, Figure 2.5A). Compromised
vascular function was assessed using the ratio of adventitial thickness to vessel lumen
diameter (i.e. wall/lumen ratio). High vascular wall/lumen ratios were indicative of
vascular remodeling and linked to increased blood pressure. Hypertensive AGMs have
greater wall/lumen ratios in renal arterioles >100 micrometers in diameter (NT 0.11±0.01
vs HT 0.15±0.02, p<0.05, Figure 2.5B).

2.3.6 Hypertensive Animals Have Altered Glomerular Morphology

Renal vascular and glomerular structures were assessed in male NT and HT animals.
Using color thresholding analysis (ImageJ), Bowman’s capsular space was greater in
glomeruli of HT animals compared with NT animals (NT 30.86±1.88% vs HT
44.44±3.14%, p<0.05). Glomeruli of HT animals show an increase in nonvascular or
open area space when compared to glomeruli of NT animals (Figure 6).
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2.4 Discussion
This study characterizes a model of spontaneous hypertension in Chlorocebus
aethiops sabaeus, the African Green Monkey of the Caribbean or vervet. Blood pressure
phenotyping was conducted in 424 animals and included both island inhabiting animals
(n= 260) as well as captivity bred and raised vervets (n= 164), with no differences in
incidence or elevation of blood pressure between the two populations. HT animals have a
significantly higher SBP, DBP, and MBP compared to BHT and NT animals (p<0.05).
In this study, 37% of the adult AGMs have SBPs over 140 mmHg while under
light ketamine sedation. This high percentage of animals with hypertension mirrors the
American Heart Association’s estimation that 33% of Americans have high blood
pressure (Go, Mozaffarian et al. 2014). It is important to note that the AGMs in the
colony population were not bred for or specifically selected for inclusion in this study due
to the presence of the pathology; nor were the animals on unique diets to induce
hypertension. Instead, this study identifies a subset of adult AGMs that display
hypertension as a spontaneous pathology with no known etiology.
Similar to humans, age was associated with a higher risk of the development of
hypertension in the AGM. The kernel density estimation in Figure 3 illustrates the
different age distributions of each group in the subset of age-known animals. The age of
NT animals is skewed heavily to younger ages while the density of the HT animals
increases as the age increases. On average, the typical hypertensive monkey is 4 years
older than the average normotensive monkey in this study; however, the sample size of
animals with known ages is smaller than the total cohort. It is already well known that
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age is an important factor in the etiology of hypertension, cardiovascular disease, and end
stage renal disease in humans (Sun 2015, Buford 2016). Future longitudinal studies will
further assess the development of hypertension and associated diseases with increasing
age in this nonhuman primate model.
Heart rate is higher in the hypertensive AGM. Elevated heart rate has been
associated with cardiovascular mortality in patients with and without
hypertension(Gillman, Kannel et al. 1993, Seccareccia, Pannozzo et al. 2001). The
elevated heart rate in the AGM mimics the pathologies seen in human essential
hypertensive patients with increased sympathetic drive(Esler 2000). These similarities
suggest that the AGM and human essential hypertensives may share common etiologies
in the development of cardiovascular disease and hypertension.
The renin angiotensin system (RAS) contributes to human hypertension in some
but not all patients. With this knowledge and the contribution of the renin-angiotensin
system to the maintenance of sodium and water homeostasis, we found it imperative to
investigate the contribution of the RAS to elevated blood pressure in the Caribbean
vervet. Angiotensinogen gene expression, renal cortical renin content, and plasma renin
activity were similar between NT and HT male AGMs (Figure 4). This would suggest
that the HT AGM maintains normal RAS activation compared to NT animals, though the
authors accept that the use of only male animals in these measurements are a limitation of
this study. Prior studies have shown that administration of captopril, an angiotensin
converting enzyme inhibitor, lowers blood pressure in hypertensive AGMs(Martin,
Palmour et al. 1990), although circulating plasma levels of Angiotensin II have been
reported as lower in animals with high blood pressure(Martin, Palmour et al. 1990).
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Interestingly, a long-term experiment found that elevated dietary sodium increases blood
pressure in adult AGMs, although components of the RAS were not measured. Animals
with low and high mean blood pressures on sodium deficient control diets (0%) tended to
maintain their relative blood pressure ranking throughout the study, while all mean blood
pressures increased with elevated sodium intake(Srinivasan, Dalferes et al. 1984). This
suggests that the AGM, or perhaps a subset of AGMs, are salt-sensitive, though the exact
role of the RAS and dietary sodium intake in AGMs with spontaneous hypertension will
need to be clarified in future studies.
Hypertension in humans and animal models is often associated with reductions in
lumen diameter and increases in wall/lumen ratios(Renna, de Las Heras et al. 2013).
Increases in renal vessel wall thickness and renal vessel wall/lumen ratio are indicative of
renal vascular remodeling in the AGM. Changes in Bowman’s capsule space suggest
glomerular alteration in hypertensive AGMs, though functional studies are still needed to
assess changes in glomerular filtration. Previous studies conducted in the hypertensive
AGM found no difference in afferent arteriole lumen diameter, AA media cross-sectional
area, or glomerular number or size between 7 NT and 7 HT adult male AGMs(Skov,
Hamet et al. 2001). However, our data focuses specifically on renal vessels with
diameters larger than 100μm and illustrates that the HT AGM undergoes
pathophysiological changes in renal vasculature and glomeruli that mimic those of
patients with essential hypertension and are associated with a higher risk of developing
chronic cardiovascular and renal disease.
Previous studies utilizing the AGM have shown that the hypertension in these
animals is heritable as parental blood pressure has a significant effect on the blood
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pressure of first generation offspring. A mixed breeding paradigm (NT/NT, NT/HT, and
HT/HT) produced a tri-modal distribution of blood pressures for both male and female
AGMs that was detectable as early as year one in progeny(Kraft-Schreyer, Kushner et al.
1987, Kraft-Schreyer, Kushner et al. 1991). These data suggest that genetic factors play a
role in the development of spontaneous hypertension, similar to human patients. The
recent sequencing and annotation of the AGM genome will accelerate the ability of
researchers to utilize this model in combination with advanced genetic techniques to
identify genes that contribute to both the heritability and pathophysiology of
hypertension(Jasinska, Lin et al. 2012, Flicek, Amode et al. 2014).
Current therapies for the treatment of hypertension can be effective, but the
clinical utilization of these drugs and targets are currently limited to random and
subjective choices for initial patient treatment. The need exists for a large animal model
of spontaneous hypertension that is genetically, behaviorally, and physiologically similar
to human disease. The AGM is a model of spontaneous hypertension that shares many
similarities with human hypertensive patients. In this novel nonhuman primate model,
researchers can take advantage of the highly similar gene sequence, structure, circadian
rhythmicity, and social behavior of primates at the basic science level. In addition, the
physiological similarities between this experimental animal model and the intended
clinical endpoint, patients, should increase the speed and efficacy of the translational
application of discoveries. The AGM offers a rare opportunity for researchers to
experimentally manipulate and control variables considered unique to primates, such as
development, pregnancy, social stressors, diet, and gut microbiota contributions to the
development of hypertension. Utilization of this highly translational nonhuman primate
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model may elicit new, more effective therapies for the treatment of hypertension and
associated cardiovascular and renal diseases.
Perspectives and Significance
The current study describes renal pathologies associated with spontaneous hypertension
in a novel non-human primate model of hypertension, the African Green Monkey. HT
AGMs exhibit vascular hypertrophy and glomerular remodeling compared to NT controls
and older animals are more likely to develop high blood pressure in this species. The
characterization of this model of hypertension opens new possibilities for researchers to
study the etiology of this disease.
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Table 2.1: Descriptive Statistics of SBP, DBP, MBP, and HR, separated by phenotype
and sex.

Phenotype

Sex

N

Systolic
Blood
Pressure
(mmHg)

Diastolic
Blood
Pressure
(mmHg)

Mean Blood
Pressure
(mmHg)

Heart Rate
(bpm)

Normotensive

Male

13
0

99.3±1.2

53.5±1.4

68.8±1.2

117.3±2.0

Female

57

100.4±1.8

62.3±2.6

75.3±3.9 144.9±3.9*

Borderline
Hypertensive

Male

58

130.9±0.7

66.2±2.6

87.7±1.8

Female

22

130.0±1.3

75.6±4.0

93.7±2.6 164.5±6.3*

Hypertensive

Male

11
9

171.6±2.4

81.6±2.3

111.6±2.0

Female

38

173.3±4.9

87.9±3.2

114.0±3.3 162.3±4.9*

60

128.2±2.5

130.3±2.0

Figure 2.1: Hypertensive AGMs have higher systolic, diastolic, and mean blood pressures
and comprise 37% of the total population studied.
Animal blood pressures (n=424) were measured by forearm cuff plethysmography under
light ketamine sedation (15mg/kg). NT AGMs (n=187, white) have an average systolic
blood pressure of 99.63±1.04 mmHg, an average diastolic blood pressure of 56.20±1.23
mmHg, and an average mean blood pressure of 79.76±1.04 mmHg. BHT AGMs (n=80,
hashed lines) have an average systolic blood pressure of 130.64±0.65 mmHg, an average
diastolic blood pressure of 68.74±2.22mmHg, and an average mean blood pressure of
89.35±151 mmHg. HT AGMs (n=157, black) have an average systolic blood pressure of
172.04±2.18 mmHg, an average diastolic blood pressure of83.13±1.91 mmHg, and an
average mean blood pressure of 112.18±1.68 mmHg. *p<0.05 when compared to NT;
^p<0.05 when compared to BHT
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Figure 2.2: Heart rate is elevated in hypertensive and borderline hypertensive AGMs
compared to normotensive AGMs.
Figure 2.2A: NT AGMS (n=148, white) have an average HR of 121.93±1.98 bpm, BHT
AGMs (n=72, hashed lines) have an average HR of 129.72±2.39bpm and HT AGMS
(n=119, black) have an average HR of 135.87±2.20 bpm. *p<0.05 compared to NT
AGMs. Figure 2.2B: Adult male AGMs (n=281, white dotted) have lower heart rates than
female AGMs (n=58, black dotted; 124.81±1.29 bpm vs. 146.24±3.59 bpm). *p<0.05
compared to male HR (Student’s t-test) Figure 2.2C: Heart rate is higher in Hypertensive
animals and in females, but no significant interactions exist between phenotype and sex.
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Figure 2.3: Hypertensive AGMs are older than the normotensive cohort.
Figure 2.3A: On average, NT AGMs (n=42, white) are 8.88±0.62 years of age while HT
AGMs (n=52, black) are 12.40±0.74 years of age. BHT AGMs (n=32, hashed lines)
average 11.00±0.87 years old. Figure 2.3B: Kernel density estimation representative of
the age distribution within each phenotypic population. NT: dotted line; BHT: dashed
line; HT: solid line. *p<0.05 compared to NT.
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Figure 2.4: Components of the renin-angiotensin-aldosterone system are similar between
normotensive and hypertensive AGMs.
Figure 2.4A: Gene expression of Angiotensinogen (AGT) is similar in the renal cortex,
renal outer medulla, and liver of hypertensive and normotensive AGMs. AGT expression
in the cortex, NT (n=14) vs. HT (n=14): 1.00±0.37 vs. 1.00±0.45; AGT expression in the
outer medulla, NT (n=12) vs. HT (n=11): 1.00±0.19 vs 0.52±0.24; AGT expression in the
liver, NT (n=17) vs. HT (n=14): 1.00±0.14 vs. 1.16±0.16. p>0.05 for all compared by
Mann-WhitneyU test. Figure 2.4B: Renal cortical renin content (RCRC) was similar in
NT and HT AGMs. NT AGMs (n=11) have an average RCRC of 8.94±1.56 ug
AngII/ml/hr/mg protein while HT AGMs (n=13) have an average of RCRC of
10.73±2.98 ug AngII/ml/hr/mg protein. p=0.62 using Student’s t-test. Figure 2.4C:
Plasma renin activity (PRA) was similar in normotensive (n=15) and hypertensive (n=16)
AGMs. Normotensive AGMs had PRA of 3.27±0.36 ng AngI/ml/hour while
hypertensive AGMs had PRA of 3.34±0.48 ng AngI/ml/hour. P=0.917 using Student’s ttest.
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Figure 2.5: Renal vascular hypertrophy is displayed in HT AGMs.
Figure 2.5A: HT AGMs have greater vessel wall thickness in renal vasculature
(14.41±0.56μm, n=8) compared to NT AGMs (10.33±1.27μm, n=8). Figure 2.5B: HT
AGMs have larger wall/lumen ratios in renal arterioles over 100μm in diameter
(0.15±0.01, n=8) compared to NT AGMs (0.11 ± 0.01, n=8) Figure 2.5C: Representative
histological sections of Periodic Acid Schiff stained renal tissue in NT and HT AGMs.
* denotes p ≤0.05 comparing NT vs. HT.
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Figure 2.6: Altered glomerular morphology identified in HT AGMs.
Figure 2.6A: HT AGMs have greater Bowman’s capsular space within glomeruli
(44.44±3.14%, n=5) compared to NT AGMs (30.86±1.88%, n=5). Capsular space was
measured by thresholding analysis of digital images of Periodic Acid-Schiff stained renal
tissue (n=5). *p≤0.05 NT vs. HT. Figure 2.6B: Histological sections of PAS-stained
glomeruli before and after ImageJ thresholding.
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3.1 Introduction
Hypertension is a major risk factor for cardiovascular disease, affecting an estimated
86 million adults and costing over $51 billion annually in the United States (Benjamin,
Blaha et al. 2017). The fact that hypertension is a complex, multifactorial disease with
numerous co-morbidities makes treatment difficult and expensive. While many strides
have been made in the treatment and prevention of cardiovascular and renal disease, an
estimated 13.7% of patients still have uncontrolled blood pressure (defined as systolic
blood pressure over 140 mmHg while on three or more classes of anti-hypertensive
medications)(Benjamin, Blaha et al. 2017). Historically, hypertension research has been
conducted largely in rat and more recently murine models of hypertension that are either
selected for genetically (Okamoto, Tabei et al. 1966, Dahl, Knudsen et al. 1967, Rapp
and Dene 1985, Bachmann, Peters et al. 1992, Shimokama, Haraoka et al. 1998) or
induced by pharmacological, dietary, or surgical interventions (Arnal, Warin et al. 1992,
Navar, Zou et al. 1998, Cosenzi, Bernobich et al. 2002, Zimmerman, Lazartigues et al.
2004). Despite this research, there remain significant numbers of hypertensive patients
that are resistant to current therapies. This gap suggests that new models and techniques
need to be studied in order to identify possible targets and novel therapies to deal with
this cardiovascular pathology. Recently, our group has focused on the African Green
Monkey as a large animal model of spontaneous hypertension that may offer new
mechanisms of the disease and bridge this translational gap (Rhoads, Goleva et al. 2017).
Studies have demonstrated that hypertension is sexually dimorphic and age-related in
patient populations. Women have lower blood pressure compared to age-matched men
until menopause(Cheng, Xanthakis et al. 2012). After the onset of menopause, women
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develop hypertension at rates equal to or greater than that of males. Women and men
even respond to anti-hypertensive medications differently: men have greater decreases in
ambulatory blood pressure in response to ACE inhibitors, while women have greater
decreases in blood pressure in response to diuretics, angiotensin receptor blockers, and
calcium channel blockers(Zimmerman and Sullivan 2013). These sex-specific responses
to different classes of anti-hypertensive medications underscore the compelling need for
translational cardiovascular research that considers sex as a crucial biological variable.
The kidney is a critical mediator of long-term blood pressure control and body fluid
homeostasis. Parallel shifts in the pressure-natriuresis curve are associated with the
development and maintenance of hypertension in both patients and experimental animal
models(Hall, Mizelle et al. 1990). In normal conditions, increases in arterial blood
pressure are associated with increased urinary sodium and water excretion, allowing
extracellular fluid volumes to decrease and blood pressure to return to normal levels. The
parallel resetting of the pressure-natriuresis curve occurs in pathological conditions and
thus inhibits the feedback cycle of body fluid homeostasis, allowing the chronic elevation
of blood pressure to continue without compensatory increases in sodium and water
excretion. Clearly, multiple neurogenic, hormonal, renal and immunological systems can
alter the sensitivity of the pressure-natriuresis curve(Akita, Sacks et al. 2003).
Urinary protein excretion across species is a clinical marker for renal damage. In
patients, proteinuria is correlated with the rate of decline in glomerular filtration rate
(GFR) and thus the progression of renal damage in hypertension and associated renal
pathologies. In the spontaneously hypertensive rat (SHR), urinary protein excretion
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increases with blood pressure and age(Feld, Van Liew et al. 1977) and differs between
age-matched male and female SHR(Reckelhoff, Zhang et al. 2000).
Thus, knowledge of critical clinical markers, with careful regard of sex and blood
pressure phenotypes, are needed to further identify causal mechanisms that contribute to
the pathogenesis of hypertension in the AGM. This study expands upon the prior
characterizations of the model (Kraft-Schreyer, Kushner et al. 1987, Martin, Palmour et
al. 1990, Skov, Hamet et al. 2001, Rhoads, Goleva et al. 2017)and provides relevant renal
function data in both male and female AGMs with normal and elevated blood pressures.
In this work, we test the hypothesis that elevations in urinary protein excretion are related
to elevation of arterial pressure in the HT AGM.
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3.2 Methods
3.2.1 Animal care and housing

Animal protocols strictly adhere to both the NIH Guide on the Care and Use of
Laboratory Animals(Animals 2011) and “Guiding Principles on the Care and Use of
Experimental Animals” published by the American Physiological Society. Protocols were
reviewed and approved by the Institutional Animals Care and Use Committee (IACUC)
of the Biomedical Sciences Research Group and SKN Primates in Basseterre, St. Kitts
and Nevis, West Indies. Animals were housed in the long term in troop enclosures in a
large outdoor facility in St. Kitts, West Indies. Animals were fed nonhuman primate
chow (Teklad 8773, Harlan) daily and a seasonal combination of fresh fruit and
vegetables (bananas, mangos, sweet potatoes, carrots and squash) on alternating days.
Water was provided ad libitum. Quarantine and husbandry protocols were maintained as
previously described (Rhoads, Goleva et al. 2017).

3.2.2 Blood pressure measurements
Animals were sedated (ketamine, 15mg/kg i.m.) and blood pressure measured as
described previously in detail (Rhoads, Goleva et al. 2017). After sedation, animals were
placed in a supine position and a blood pressure cuff placed on the left upper arm. A
Doppler stethoscope was used to confirm total occlusion and identify Korotkoff sounds
indicative of systolic (SBP) and diastolic blood pressures. Animals were characterized as
normotensive (NT, SBP ≤ 120 mmHg), pre-hypertensive (PHT, SBP between 120 and
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140 mmHg), or hypertensive (HT, SBP ≥ 140 mmHg) based on repeated measurements
of SBP.

3.2.3 Urine collection and sample preparation
Prior to study, animals were moved from group enclosures into singly housed
metabolic pens with 1 L water bottles for the duration of the studies (n=120). The dietary
regimen remained the same and animals were fed non-human primate chow (Teklad
8773, Harlan), fresh fruits, and vegetables as described above. Female animals were
monitored and examined for pregnancy, and if found to be pregnant, were removed from
this cohort. After a minimum 7-day acclimation period, blood pressures were measured
as described above and whole blood collected in Li-heparinized tubes. Urine was then
collected for 3 consecutive, 24-hour periods. Water intake and urine volume were
recorded daily. Urine samples were centrifuged (1000xg) to remove any large particulate
contaminants. Samples were aliquoted into 1.5 mL tubes to minimize freeze-thaw cycles
during further downstream analysis and stored at -20°C.

3.2.4 Urinary protein measurement
Total protein concentration was measured by Pierce BCA Assay (Catalog #
23225, ThermoFisher Scientific, Waltham MA) per the manufacturer’s recommended
protocol. Briefly, urine samples were diluted 1:4 and 25 μL of bovine standard albumin
or thawed samples were pipetted in a microplate. Working BCA reagent (200 ul) was
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added to each well and the plate incubated at 37°C for 2 hours. After cooling to room
temperature, absorbance was read at 595nm. A linear standard curve was generated (r2 ≥
0.98) and used to determine protein concentration for the unknown samples.

3.2.5 Urinary and plasma creatinine measurements/estimation of glomerular filtration rate
Urinary creatinine was measured by a modified Jaffe reaction(Husdan and
Rapoport 1967) or by plasma creatinine assay following the manufacturer’s
recommended protocol (Item #: 700460, Cayman Chemical, Ann Arbor, MI). Urine
samples were diluted 20x. Briefly, known creatinine standard or thawed, diluted urine
samples (50 ul) were combined with 100 μL of alkaline picrate (12.5 mL of 0.13% picric
acid and 2.5mL of 1 M NaOH). After 30-minute room temperature incubation,
absorbance was read at 490 nm. A linear standard curve was generated (r2 ≥ 0.98) and
used to determine creatinine concentration for the unknown samples. Estimated
glomerular filtration rate (eGFR) was calculated by the equation:

𝑒𝐺𝐹𝑅 =

𝑈𝑟𝑖𝑛𝑒 𝐹𝑙𝑜𝑤 𝑅𝑎𝑡𝑒 𝑥 𝑈𝑟𝑖𝑛𝑒<=>?@ABAB>
𝑃𝑙𝑎𝑠𝑚𝑎<=>?@ABAB>

3.2.6 Urinary sodium and potassium measurements
Urinary sodium and potassium concentrations were measured by dual-channel
flame photometry (Dual-channel flame photometer #02655-10, Cole-Parmer, Vernon
Hills, IL). Thawed urine samples were diluted 20X in lithium diluent and concentrations
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multiplied by dilution factor, molecular weight, and the appropriate urine flow rate (UFR)
to obtain ion excretion rates.

3.2.7 Statistical analysis
Data was analyzed using SPSS 21.0 (IBM) and groups were compared by
ANOVA with Tukey’s post-hoc analysis or Student’s t-test when appropriate. Values are
presented as mean±SEM and p<0.05 used as the criterion of significance.
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3.3 Results
3.3.1 Cohort blood pressure
Blood pressure was measured in 119 adult AGMs (male: n=50) under light
sedation. NT animals (n=40) averaged SBPs of 106.3±2.1 mmHg, diastolic blood
pressures (DBP) of 41.5±2.2 mmHg, and mean blood pressures (MBP) of 84.7±1.8
mmHg. PHT animals (n=33) averaged SBPs of 130.5±1.0 mmHg, DBPs of 53.6±3.6
mmHg, and MBPs of 104.9±1.5 mmHg, while HT animals (n=46) averaged 166.0±4.2
mmHg, 68.1±4.8 mmHg, and 133.4±3.3 mmHg for SBP, DBP, and MBP, respectively.
SBP, DBP, and MBP are all significantly different between all groups (p<0.05, Figure
3.1).

3.3.2 Daily water intake and urine flow rate
Daily water intake is similar in NT (231.9±32.2 mL/day, n=40), PHT (209.6±22.2
mL/day, n=33), and HT (241.9±26 mL/day, n=46; p>0.05; Figure 3.2A) AGMs and does
not differ between male (200.2±22.2 mL/day, n=50) and female (250.9±22 mL/day,
n=69; Figure 3.2B) animals. Daily water intake is also similar between the sexes in each
of the blood pressure groups (NT females: 258.4±42.7 mL/day, n=28; NT males:
170.1±36.2 mL/day, n=12; PHT females: 221.7±27.4 mL/day, n=24; PHT males:
177.2±35.5 mL/day, n=9; HT females: 279.9±40.6 mL/day, n=17; HT males: 219.7±33.6
mL/day, n=29; Figure 3.2C).
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Urine flow rates are similar in NT (137.7±17.1 mL/day, n=40), PHT (152.4±16.4
mL/day, n=33), and HT (165.6±16.1 mL/day, n=46; p>0.05; Figure 3.2D) groups and do
not differ between male (138.0±12.7 mL/day, n=50) and female (163.1±13.7 mL/day,
n=69; Figure 3.2E) animals. Urine flow rate is also similar between the sexes in each of
the blood pressure groups (NT females: 159.1±22.5 mL/day, n=28; NT males: 87.7±15.2
mL/day, n=12; PHT females: 146.9±18.7 mL/day, n=24; PHT males: 167.0±35.4
mL/day, n=9; HT females: 192.3±32.4 mL/day, n=17; HT males: 150.0±16.8 mL/day,
n=29; Figure 3.2F).

3.3.3 Estimated glomerular filtration rate (eGFR)
eGFR is similar in NT (3.5±0.4 mL/min, n=32), PHT (4.3±0.5 mL/min, n=25),
and HT (4.6±0.5 mL/min, n=36; p>0.05) animals (Figure 3.3A) and does not differ
between sex (males: 4.3±0.5 mL/min, n=39; females: 4.0±0.3 mL/min, n=54; Figure
3.3B). eGFR is also similar between the sexes of each blood pressure group (NT females:
3.6±0.5 mL/min, n=23; NT males: 3±0.8 mL/min, n=9; PHT females: 4.3±0.4 mL/min,
n=20; PHT males: 4.4±2.1 mL/min, n=5; HT females: 4.2±0.8 mL/min, n=11; HT males:
4.7±0.6 mL/min, n=25; Figure 3.3C).

3.3.4 Urinary protein excretion
Protein excretion is elevated in HT and PHT AGMs (HT: 457.7±22.4 mg/day,
n=46; PHT: 424.2±29.6 mg/day, n=31) compared to NT animals (NT: 336.2±19.5
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mg/day, n=40; p<0.05; Figure 3.4A). Protein excretion is similar between male
(427.4±23.3 mg/day, n=50) and female (392.3±17.8mg/day, n=67) AGMs (Figure 3.4B).
Protein excretion is also similar between sexes of each blood pressure phenotype group
(NT females: 359.9±24.2 mg/day, n=28; NT males: 281±27 mg/day, n=12; PHT females:
410.9±34.4 mg/day, n=22; PHT males: 456.7±59.3 mg/day, n=9; HT females:
421.7±34.5 mg/day, n=17; HT males: 478.9±28 mg/day, n=29; Figure 3.4C).

3.3.5 Urinary sodium and potassium excretion
Sodium excretion is elevated in HT AGMs (3.6±0.3 mmol/day, n=46) compared
to NT animals (2.2±0.2 mmol/day, n=40; p<0.05). PHT animals excrete 3.0±0.3
mmol/day (n=33) of sodium and are not significantly different from either NT or HT
animals (Figure 3.5A). Male AGMs (3.4±0.2 mmol/day, n=50) excrete higher amounts of
sodium daily compared to female AGMs (2.7±0.2 mmol/day, n=69; p<0.05, Figure
3.5B). Sodium excretion is similar between sexes within phenotypic groups (NT females:
2.2±0.2 mmol/day, n=28; NT males: 2.4±0.3mmol/day, n=12; PHT females: 3±0.4
mmol/day, n=24; PHT males: 3.4±0.5 mmol/day, n=9; HT females: 3.2±0.2 mmol/day,
n=17; HT males: 3.8±0.3 mmol/day, n=29; Figure 3.5C).
Potassium excretion is elevated in HT AGMs (4.0±0.4 mmol/day, n=46)
compared to NT AGMs (2.7±0.3 mmol/day, n=40, p<0.05). PHT animals excrete 3.7±0.4
mmol/day of potassium (n=32) and are not significantly different from either NT or HT
animals (Figure 3.5D). Female and male AGMs have similar levels of daily potassium
excretion (Female: 3.5±0.3 mmol/day, n=68; Male: 3.4±0.3 mmol/day, n=50, Figure
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3.5E). Daily potassium excretion is similar between sexes within phenotypic groups (NT
females: 2.8±0.3 mmol/day, n=28; NT males: 2.4±0.6 mmol/day, n=12; PHT females:
3.7±0.4 mmol/day, n=23; PHT males: 3.7±0.6 mmol/day, n=9; HT females: 4.5±0.8
mmol/day, n=17; HT males: 3.7±0.4 mmol/day, n=29; Figure 3.5F).
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3.4 Discussion
We have previously reported that 37% of adult AGMs have SBPs greater than
140 mmHg in our cohort (n=424) and that HT animals are typically older and have
increased heart rates compared to normotensive controls, as well as renal vascular and
glomerular pathologies (Rhoads, Goleva et al. 2017). In the current study, water intake
and urine flow rates were similar in NT, PHT, and HT groups (p>0.05), suggesting that
water balance is similar in all groups, regardless of blood pressure phenotype or sex
(Figure 3.2). On average, animals consume 229.6 ± 15.9 mLs of water daily and have an
average urine flow rate of 152.5 ± 9.6 mL/day. It’s crucial to consider that movement of
animals from troop enclosures to single housing may cause an elevated stress response
due to removal from the troop, though single housing is necessary to accurately collect
urine and measure water intake (Kurien, Everds et al. 2004). Animals are still able to see,
smell, and hear their troop while in single housing and great efforts are made to reduce
time in single housing as much as possible. Animals acting as though under severe duress
would be removed immediately from the study, however, the altered living environment
is a consideration in the interpretation of the current work.
Declining eGFR is an established marker of kidney function in hypertensive
patient populations and decreases as disease states progress. Here we report no significant
differences in baseline eGFR in NT, PHT, and HT AGMs, with eGFR averaging 4.1±0.3
mL/min in the entire cohort. However, it is worth noting that the rate of eGFR decline
varies in different patient populations, regardless of SBP load and other risk
factors(Davidson and Hix 2006) . In addition, the well-documented age-related decline of
eGFR has been shown to have large amounts of individual variability in humans
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(Glassock and Winearls 2009, Weinstein and Anderson 2010). Imai et al. found that
proteinuria and lowered eGFR may be risk factors for future declines in eGFR and
diagnosis of disease states, such as end stage renal disease(Imai, Horio et al. 2007).
Future longitudinal analysis of eGFR in this AGM cohort will provide further
information on the association between changes in eGFR, sex, age, and severity of
hypertension progression in this model species.
Comparatively, eGFR is 10.4 ml/min in the rhesus macaque(Davies and Morris
1993), a non-human primate of similar size. To date, no one has reported spontaneous
elevation of blood pressure in the rhesus macaque. The varied habitats of the rhesus
macaque compared to the Sub-Saharan savannah habitat of the AGM may have
evolutionarily selected for the AGM to exist in a more hypovolemic state compared to the
rhesus macaque. This proposed perpetual dehydration may explain lower eGFRs in
comparison to the rhesus macaque and may contribute to the development of spontaneous
hypertension in the AGM.
Hypertensive AGMs exhibit elevated urinary protein, sodium and potassium
excretions compared to normotensive controls (Figure 3.4). In conjunction with our
previously published data that HT AGMs display altered glomerular
morphology(Rhoads, Goleva et al. 2017), excess protein excretion is likely indicative of
renal damage at some level correlated with chronic elevation of blood pressure, similar to
patients with hypertension, chronic kidney disease(Jafar, Stark et al. 2003),
cardiovascular disease(Irie, Iso et al. 2006), diabetes(Borch-Johnsen, Andersen et al.
1985), and hypertensive pregnancy disorders(Murakami, Saitoh et al. 2000).
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Urinary protein excretion is not just a marker of renal damage, but may also be
responsible for the exacerbation during the pathogenesis of renal disease. High levels of
protein in the glomerular filtrate increase protein reabsorption in proximal tubular cells to
maintain glomerular-tubular balance, which then accumulate abnormal levels of protein
in the endolysosomes and endoplasmic reticulum. This abnormal protein accumulation
can initiate the transcription of many oxidative stress, inflammatory, remodeling, and
vasoactive genes, including (but not limited to) nuclear factor kappa beta, monocyte
chemoattractant protein-1, and endothelin-1(Remuzzi, Ruggenenti et al. 1997). Future
studies will focus on localization of the renal damage as well as pathogenic consequences
of this increased protein load to the kidney in this novel model of spontaneous
hypertension.
Sodium and potassium excretion is higher in HT animals compared to NT and
PHT animals (Figure 3.5). While all animals have access to the same amount of dietary
sodium and potassium (estimated 6.5 mmol/day and 15.4 mmol/day, respectively), it is
possible that HT animals consume more food and thus elevate filtered load and
electrolyte excretion. It is also possible that prior to single housing, HT animals
competitively obtained more food in the troop enclosure and retained excess sodium from
this time period. It’s important to note that while dietary intake has been estimated based
on the non-human primate chow formulation, actual intake varies for each animal and is
dependent on a number of factors currently outside of experimental control (including
group behavior, personality, weather, etc). The authors are currently pursuing options to
more accurately determine food intake for individual animals but do recognize this factor
as a limitation to the current work.
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Srinivasan and colleagues found that a small group of AGMs (n=14) had
elevation of systolic and diastolic blood pressures in response to long-term increases in
dietary NaCl.(Srinivasan, Dalferes et al. 1984). Baseline blood pressures were obtained
while AGMs were fed a 0% NaCl diet for 45 days. Then, dietary NaCl was increased to
3%, 4.5% and 6% over varied time periods (139, 37, and 90 days, respectively). Animals
with low or high baseline blood pressures tended to maintain their ordinal positioning
within the cohort while on the control and high salt diets, suggesting that individual
animals have other unknown factors that contribute to their higher blood pressures.
AGMs, as a species, have blood pressure control mechanisms that respond to increased
dietary NaCl similarly to the 60% of patients with salt-sensitive hypertension(Haddy
2006) and like humans, hypertension in the AGM can be mediated by genetic and
environmental factors. Since the AGM has not been specifically bred for the presence of
hypertension, and yet the phenotype persists, the species represents a novel opportunity to
study these complex factors in a laboratory setting.
Sodium excretion is higher in male AGMs compared to female animals (Figure
3.5B) but there are no differences in water intake, urine flow, protein excretion, or
potassium excretion. In humans, sex hormones, such as estrogen affect the pressurenatriuresis relationship, which may contribute to the ‘protection’ from the prevalence of
hypertension seen in pre-menopausal women compared to age-matched men(PechereBertschi and Burnier 2004). It’s likely that the result seen here is simply a factor of
sexually dimorphic body size in the species, as males tend to be larger than females.
This work identifies key physiological parameters crucial to blood pressure
control in a novel model of spontaneous hypertension, the African Green Monkey.
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Similar to humans, animals with chronic elevation of blood pressure have proteinuria
compared to normotensive controls. Identification of the mechanisms that contribute to
the development and maintenance of this elevated blood pressure and associated protein
excretion in this non-human primate may lead to the creation of new, more effective
interventions for the treatment of hypertension in human patients. In addition, this work
adds to the characterization of hypertension and associated pathologies in the AGM,
creating a foundational baseline to address new research questions in this model species.
Perspectives and Significance
With the increasing focus on translational science that can be quickly adapted to
clinical practice, it is critically important that basic science researchers utilize appropriate
model organisms to address their research questions. The African Green Monkey
represents a novel large animal model organism highly relevant to the study of
hypertension and cardiovascular disease with pathological similarities to patient
populations and the presence of hypertension in lieu of specialized breeding paradigms or
experimental interventions. With this unique model species, researchers can address the
complex interactions between disease pathologies, genetic factors, social dynamics, and
environmental contributions to the development and maintenance of hypertension, which
we hope will provide new targets and more effective therapies for the treatment of
patients, particularly those individuals that are resistant to current antihypertensive
interventions.
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Figure 3.1: Average systolic (SBP), diastolic (DBP), and mean blood pressure (MBP) of
the 119 adult African Green Monkeys in the metabolic cohort.
SBP, DBP, and MBP are significantly different in each blood pressure phenotype group,
(p<0.05, ANOVA with Tukey’s post hoc comparison). * denotes p>0.05 compared to
normotensive; ^ denotes p<0.05 compared to pre-hypertensive.
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Figure 3.2: Average daily water intake and urine flow rate are similar in the metabolic
cohort.
Average values obtained during the 3 day metabolic pen experiments are shown by blood
pressure phenotype (2A & 2D), sex (2B & 2E) and sex/phenotype groups (2C & 2F).
There are no significant differences in water balance in any of the comparisons (p>0.05,
ANOVA with Tukey’s post hoc comparisons).
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Figure 3.3: eGFR is similar between all groups in the metabolic cohort.

Estimated glomerular filtration rate (eGFR; creatinine clearance) was similar between all
groups, including blood pressure phenotype (3A), sex (3B), and sex/phenotype groups
(3C; p>0.05, ANOVA with Tukey’s post hoc comparison).
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Figure 3.4: Hypertensive and pre-hypertensive animals have elevated urinary protein
excretion

Hypertensive and pre-hypertensive animals have increased urinary protein excretion rates
compared to normotensive animals (p<0.05, ANOVA with Tukey’s post hoc comparison)
(4A). Urinary protein excretion is similar between the sexes (4B) and sex/phenotype
groups (4C). *denotes p<0.05 compared to normotensive group
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Figure 3.5: Hypertensive animals have elevated urinary sodium and potassium excretion.
Urinary sodium (5A) and potassium (5D) excretion are increased in hypertensive animals
compared to normotensive animals (p<0.05, ANOVA with Tukey’s post hoc
comparison). On average, males excrete more sodium than females (5B; p<0.05,
Student’s t-test), but no other differences exist between the sexes or sex/phenotype
groups in ion excretion. * denotes p<0.05 compared to normotensive group. ^ denotes
p<0.05 compared to female group.
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4.1 Introduction
It is well established that the sympathetic nervous system (SNS) contributes to the
development and maintenance of hypertension and cardiovascular disease. As one arm
of the autonomic nervous system, the SNS regulates a myriad of physiological processes
known as the “flight or fight” response, including, but not limited to, blood vessel
constriction, acceleration of heart rate, pupil dilation, inhibition of digestion, and
secretion of epinephrine and norepinephrine (NE) from the adrenal cortex.
Evolutionarily, sympathetic outflow allows an organism to quickly respond to threats and
ensure survival. However, sympathetic nerve activity (SNA) is not limited to responding
to external threats and stimuli, it’s also an important regulator of arterial blood pressure
and extracellular fluid volumes. Sympathetic outflow can quickly alter the level of
vasoconstriction in the arterial vessels, which in turn changes blood flow to organs.
However, elevation of sympathetic outflow can have pathophysiological effects and
combined with a sedentary lifestyle, stress, obesity, and Western diet can contribute to
the development of many diseases in modern man.
Sympathetic outflow originates in the central nervous system and acts in the
periphery through the release of catecholamines on adrenergic receptors (ADR). ADRs
all belong to the superfamily of G-coupled protein receptors, all of which contain seven
transmembrane domains with alternating intracellular and extracellular loops (Storsberg
1993). ADRs are categorized into three major groups: α1 ADRs, which includes the
subtypes: α1A, α1B, and α1D; α2 ADRs, which has three subtypes: α2A, α2B, and α2C; and
the β ADR group, which includes the β1, β2, and β3 subtypes. Though these receptors all
respond to the same endogenous catecholamines, they activate different intracellular
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signaling cascades, suggesting that the response of an organ to SNA is based on the
quantity and types of ADRs present. In the heart, β ADRs are the primary ADR group
expressed, with β1 ADRs outnumbering β2 ADRs in an approximate 3:1 ratio,
respectively (Iaccarino, Barbato et al. 2001). Activation of cardiac ADRs can lead to
changes in contractile rate and force, blood pressure, and intracellular calcium signaling,
and has been shown to shown to induce cardiac hypertrophy in transgenic mice
overexpressing β1 ADRs in the myocardium (Barki-Harrington, Perrio et al. 2004).
While cardiac hypertrophy occurs in part due to the increased afterload that the
heart muscle must contract against, genetic variation accounts for a significant portion of
the hypertrophic variability observed in both patients (Verhaaren, Schieken et al. 1991, Fu,
Wang et al. 2008) and animal models of hypertension (Tanase, Yamori et al. 1982).
Schlaich and colleagues found that hypertensive patients with left ventricular hypertrophy
(LVH) had excess cardiac NE spillover as a direct result of increased cardiac sympathetic
stimulation. Interestingly, nonhypertrophic hypertensive patients did not display cardiac
NE spillover but had similar amounts of renal NE spillover and plasma NE compared to
the LVH hypertensive patients (Schlaich, Kaye et al. 2003). This data suggests that cardiac
NE spillover, and the subsequent adrenergic activation, is necessary for the development
of LVH in hypertensive patients. In addition, both α- and β- adrenergic receptor blockade
has been shown to decrease cardiac hypertrophy, confirming that SNA is crucial to the
maintenance of LVH (Rizzi, Guimaraes et al. 2014).
Many lines of evidence have shown that renal sympathetic nerve activity is
critical to the development of primary hypertension. The kidney is highly innervated and
the majority of these nerves are adrenergic. α1 ADRs are found in the renal vasculature,
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nephrons, and proximal tubules. The distribution of the α2 ADRs is similar to the α1
ADRs, but α2 ADRs are additionally located in the collecting ducts. Renal β1 ADRs are
located in the juxtaglomerular cells, distal tubules, and collecting ducts, while β2 ADRs
can be found in the proximal tubules, distal tubules, and collecting ducts. Urinary NE and
sympathetic nerve activation is increased in human hypertensive patients as well as the
spontaneously hypertensive rat (Esler and Kaye 2000, Pinto, Amaral et al. 2011). Renal
denervation prevents or delays the onset of hypertension in the multiple animal models of
hypertension (DiBona and Esler 2010) and has been shown to be effective in the
treatment of resistant hypertensive patients in some (Esler, Bohm et al. 2014), but not all
human trials, as reported in the controversial results of SYMPLICITY HTN-3 trial
(Bakris, Townsend et al. 2014). In addition, renal SNA has been shown to increase renin
secretion rate, promote sodium retention in the tubules, and decrease renal blood flow
through vasoconstriction of the renal vessels. Together, these data paint a convincing
picture of the importance of SNA and the renal ADRs in the development and
maintenance of hypertension.
The African green monkey (AGM) is a novel large animal model of spontaneous
hypertension that displays renal vascular and glomerular pathologies in conjunction with
elevated heart rate (Rhoads, Goleva et al. 2017). This work tests the hypothesis that
sympathetic outflow contributes to hypertension in the AGM by measuring indirect
indices of sympathetic activation, such as cardiac hypertrophy and gene expression of
ADRs in tissues critical to the regulation of blood pressure in conjunction with elevated
systolic blood pressures in adult male AGMs.
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4.2 Methods
4.2.1 Blood pressure measurement
Systolic (SBP) and diastolic (DBP) blood pressures were measured and phenotype
categories assigned as previously described (Rhoads et al. 2017). Briefly, animals were
lightly sedated and blood pressures measured using a forearm cuff and Doppler
stethoscope. Animals were categorized as normotensive (NT; SBP > 120 mmHg),
borderline- or pre-hypertensive (BHT; SBP between 120 and 140 mmHg) or hypertensive
(HT; SBP <140 mmHg). Heart rate was determined by counting pulsatile beats for 30
seconds while animals were sedated. Mean blood pressure (MBP) was calculated using
the equation 𝑀𝐵𝑃 =

G-HI(J∗L-H)
M

4.2.2 Tissue collection, shipment, and storage
After blood pressure measurement, selected animals (n=18) were fully
anesthetized with supplemental ketamine (25 mg/kg i.m.) and xlyazine (100 mg/kg i.m.),
then euthanized with a sodium pentobarbital overdose (150 mg/kg, i.v.; Buthenasia).
Tissues were perfused, collected, sliced into sections, and sections alternatively frozen or
fixed. For fixation, tissues were sliced into sections 3 cm in length and 3-5 mm thick.
Sections were fixed using 5% paraformaldehyde (PFA) for 72 hours with the PFA
changed at 24 hour intervals. Fixed tissues were placed in phosphate buffered saline for
transport and shipping and then placed in 70% ethanol for long term storage. Frozen
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tissues were placed in ultra-cold isopentane (-20°C) on dry ice for flash freezing. Samples
were shipped on dry ice and placed in -20°C freezer for storage.

4.2.3 Histological sample analysis
Histological samples (approximate 4 mm thickness) from NT (n=6) and HT (n=6)
animals were dissected from fixed tissue sections, as previously described in detail
(Rhoads, Goleva et al. 2017). Samples were paraffin embedded and sectioned using a
microtome at 5 µm thickness. After drying, slides were stained using hemotoxylin and
eosin. Slide images were digitally captured using an Olympus IX70 inverted microscope
and analyzed in ImageJ (Schindelin, Rueden et al. 2015). A minimum of 5 images of
each ventricular section from each animal were obtained and analyzed. The crosssectional area of all cells contained in the viewing field were measured and averaged for
each animal. Analysis was performed in a blinded fashion.

4.2.4 Quantitative real-time polymerase chain reaction
Frozen left ventricular tissue sections (n=7) were dissected into endocardium,
myocardium, and epicardium. Frozen renal sections (n=18) were dissected into cortical,
medullary (outer and inner), and papillary regions. RNA was extracted from the
myocardium, renal cortex, renal outer medulla, and renal inner medulla using the Directzol RNA kit (Zymo Research, Irvine CA), following the manufacturer’s recommended
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instructions. After extraction, cDNA was created using qScript cDNA SuperMix
(Quantabio, Beverly MA) and qPCR performed using SYBR Green (Invitrogen, Carlsbad
CA) in a StepOnePlus Real Time PCR System (ThermoFisher Scientific, Waltham MA).
Forward and reverse primer sequences can be found in Table 4.1. RPS13A was used as
the housekeeping gene in the renal cortex and myocardium, while RPS32 was used as the
housekeeping gene in the renal medulla.

4.2.5 Statistical analysis
qPCR RQs were calculated using the comparative 2-ΔΔCT method (Livak and
Schmittgen 2001) and normalized to the normotensive cohort. Data is presented as mean
± standard error. Groups were compared using Mann-Whitney U test, or ANOVA with
Tukey’s post hoc comparison with p<0.05 as the level of probability.
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4.3 Results
Blood pressure was measured in 18 NT and 18 HT adult male AGMs selected for
the qPCR and histology cohort. NT animals averaged 96.6±3.2 mmHg, 54.6±3.9 mmHg,
and 68.6±3.7 mmHg for SBP, DBP, and MBP, respectively. HT animals averaged
169.2±6.9 mmHg, 94.5±5.1 mmHg, and 119.4±3.0 mmHg for SBP, DBP, and MBP
(p<0.05 compared to normotensive, Figure 4.1).
Cardiomyocyte cross-sectional area (CSA) was assessed in the left and right
ventricle of 7 normotensive and 7 hypertensive adult male AGMs. In the right ventricle,
NT animals had an average CSA of 932.9±179.7 µm2 while HT animals had an average
CSA of 1133.5±298 µm2 (p>0.05). In the left ventricle, NT animals averaged a CSA of
791±180.6 µm2 and HT animals displayed a significant elevation of cardiomyocyte area
with an average CSA of 1658.4±210.3 µm2 (p<0.05, Figure 4.2).
Left ventricular myocardial gene expression of ADRα1A (NT 1±0.2 vs. HT
1.2±0.3), ADRα1D (NT 1±0.2 vs HT 1.2±0.3), ADRα2A (NT 1±0.4 vs HT 0.8±0.5),
ADRα2C (NT 1±0.3 vs HT 0.4±0.1) and ADRβ2 (NT 1±0.2 vs HT 1.8±0.4) is similar
between NT and HT groups. ADRβ1 left ventricular gene expression is elevated in HT
animals compared to NT animals (NT: 1±0.2 vs HT 1.9±0.4, p<0.05, Figure 4.3A &
4.3B)
Renal cortical gene expression of ADRα1A (NT 1±0.1 vs. HT 1.1±0.1), ADRα1D
(NT 1±0.1 vs HT 1±0.2), ADRα2A (NT 1±0.1 vs HT 0.8±0.1), ADRα2C (NT 1±0.2 vs
HT 1±0.2), ADRβ1 (NT 1±0.1 vs HT 0.9±0.1) and ADRβ2 (NT 1±0.1 vs HT 0.9±0.1) is
similar between NT and HT groups (Figure 4.4A & 4.4B).
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Renal outer medullary gene expression of ADRα1A (NT 1±0.4 vs. HT 2.3±0.5),
ADRα1D (NT 1±0.3 vs HT 2.2±0.3), ADRα2A (NT 1±0.2 vs HT 1.9±0.2), ADRα2C
(NT 1±0.2 vs HT 1.6±0.1), ADRβ1 (NT 1±0.2 vs HT 1.9±0.2) and ADRβ2 (NT 1±0.2 vs
HT 1.9±0.2) is elevated in HT AGMs compared to NT animals (p<0.05, in all NT vs. HT
comparisons). (Figure 4.5A & 4.5B).
Renal inner medullary gene expression of ADRα1A (NT 1±0.3 vs. HT 1.5±0.4),
ADRα1D (NT 1±0.3 vs HT 1.7±0.4), ADRα2A (NT 1±0.2 vs HT 1.4±0.3), ADRα2C
(NT 1±0.2 vs HT 1.3±0.3), ADRβ1 (NT 1±0.3 vs HT 1.4±0.3) is similar between NT and
HT groups. ADRβ2 gene expression is elevated in the renal inner medulla of HT animals
compared to NT animals (NT 1±0.3 vs HT 1.6±0.1, p<0.05, Figure 4.6A & 4.6B)
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4.4 Discussion
AGMs with elevated blood pressures display elevated heart rates (Rhoads, Goleva
et al. 2017), LVH, and select upregulation of alpha- and beta- ADR subtype mRNA in the
left ventricular myocardium, renal outer medulla, and the renal inner medulla. Together
these data suggest that activation of the SNS is a crucial contributor to the development
and maintenance of hypertension in this novel large animal model.
Elevation of heart rate is a risk factor for the development of heart failure,
atherosclerosis, and myocardial infarction; it is also associated with increased
cardiovascular mortality and excess sympathetic outflow (Palatini and Julius 1996,
Custodis, Reil et al. 2013). Analysis of the Framingham Heart Study identified higher heart
rates as associated with adverse prognoses, increased risk of cardiovascular events, and
higher all-cause mortality (Gillman, Kannel et al. 1993, Ho, Larson et al. 2014). Aronow
et al found that an increase in heart rate of 5 beats/min created 1.14x higher probability of
new coronary events in men and women older than 60 years of age (Aronow, Ahn et al.
1996), while other studies have shown that in adolescents, elevated resting heart rate is
associated with cardiovascular risk factors (Farah, Christofaro et al. 2015, Sarganas,
Schaffrath Rosario et al. 2017). These studies suggest that rapid heart rate is an independent
risk factor for the development of cardiovascular mortality and increase the translational
value of a non-human primate model that presents increased heart rate as part of the
pathology of spontaneous hypertension. Longitudinal studies that determine the predictive
value of elevated heart rates in spontaneously HT AGMs would provide a unique preclinical model for scientific research.
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β1 adrenergic receptor gene expression is also upregulated in the left ventricular
myocardium of HT AGMs, similar to the spontaneously hypertensive rat (SHR), a welldescribed model of hypertension (Iemitsu, Miyauchi et al. 2001). Ietmitsu et al also found
that mRNA expression of the β1- adrenergic receptor kinase, which mediates downstream
signaling and adrenoreceptor desensitization, was also upregulated in the SHR heart,
suggesting that the signal transduction of this G-protein coupled receptor may be impaired
in disease states in hypertrophied cardiac tissue. Furthermore, the impairment and
uncoupling of β ADRs in chronic heart failure is a well-described phenomenon. Future
studies in the HT AGMs should focus on the gene transcription of downstream signaling
events in the myocardium to determine if β1- adrenergic receptor kinase signaling is also
impaired in this model organism. In addition, polymorphisms in the β1-adrenergic receptor
have been linked to left ventricular hypertrophy in patients with essential hypertension(Fu,
Wang et al. 2008). The contribution of genetic polymorphisms in the ADRs in the
development of hypertension in the AGM is currently unknown.
The contribution of renal sympathetic nerve activation to hypertension is well
documented. Sympathetic nerves innervate the renal circulation, traveling through the
cortex and outer medulla while decreasing in number toward the inner medulla (McKenna
and Angelakos 1968), and regulate regional renal blood flow. In particular, studies from
Dr. Allen W. Cowley Jr.’s group have shown that the renal outer medulla responds to
changes in perfusion pressure in a high-salt environment. In Dahl SS rats on a 4% sodium
diet, Mori et al used a servo-control system to maintain renal perfusion pressure in the left
normotensive kidney while allowing the right kidney to be exposed to hypertensive
perfusion pressures. Comparison of microarray data between the two kidneys identified
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distinct differences in outer medullary gene expression after both 14 and 7 days
respectively (Mori, Polichnowski et al. 2008, Evans, Dayton et al. 2018), suggesting that
the renal outer medulla is sensitized to changes in perfusion pressure and that molecular
pathways mediate this response. Thus, the renal outer medulla has been identified as a
pathological ‘first responder’ region in response to changes in renal blood flow.
Gene expression of α- and β -ADR subtypes are up-regulated in the renal outer
medulla of the hypertensive AGM, although whether this observation is causal or a
consequence of the elevated blood pressure is still unknown. In regards to the functional
consequences of this observation, two possible explanations must be explored in further
investigations regarding the sympathetic contribution to hypertension in this model. First,
it’s possible that the outer medulla of the HT AGM is hyper-sensitized to sympathetic
outflow due to an increased ADR density. Experiments that assess the effects of
sympathetic activation on regional blood flow in the kidney would provide important
information on the role of the ADRs in the HT AGM. However, a limitation to the current
study is the well-documented fact that mRNA levels are not necessarily equal to protein
levels, due to factors such as mRNA decay, microRNA interactions, post-translational
modifications, and protein degradation. In addition, the documented non-specificity of
adrenergic receptor antibodies (Hamdani and van der Velden 2009, Jensen, Swigart et al.
2009) requires that ADRs be quantified using other approaches, such as radio-ligand
competitive binding assays. An additional limitation to this study is the fact that mRNA
was isolated from tissue homogenate and thus, multiple cell types. Future studies should
assess receptor density in in isolated or micro-dissected renal tissues of NT and HT AGMs
to confirm if protein levels of ADRs are also elevated. Since reports of tissue adrenergic
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receptor number and density in both patients and hypertensive animal models are
inconsistent (Michel, Brodde et al. 1990), so addition of such data in a non-human primate
model would increase the model’s translational capacity in the development of novel
therapies and interventions to treat hypertension.
Secondly, it is also possible that hypertension in the HT AGM has led to higher
levels of ADR desensitization and thus increased transcription of these receptors as a
compensatory response. In human studies, β – ADR sensitivity, as measured by the cardiac
response to isoproterenol, is decreased in older HT patients compared to age-matched NT
controls (Bertel, Buhler et al. 1980). Aging itself is a major risk factor for hypertension,
and both human and animal studies have identified pathological changes due to aging in
renal sodium handling and the response to renal sympathetic activation (Frame and
Wainford 2018). Furthermore, GPCR desensitization is a well-described occurrence and
many studies have identified impaired function of the β ADRs in hypertensive patient
cohorts, suggesting that the reduced function of the vasodilatory β ADRs promotes
hypertension via increased vasoconstriction (Ferguson and Feldman 2014). Experiments
that can elucidate the functional contribution of renal ADRs, particularly in the context of
aging, are needed in this model organism.
While our data suggests that the renal outer medulla in the HT AGM may be
sensitized to SNA in the context of chronically elevated blood pressure, in vivo experiments
that measure renal blood flow, oxidative stress, and sympathetic activation are needed to
provide more insight to the contribution of the SNS to hypertension in this model. Since
the blood pressure in the AGM has been shown to be sensitive to dietary sodium
(Srinivasan, Dalferes et al. 1984), like the Dahl SS rat, elucidating the roles of the ADRs,
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SNA, and blood pressure in the presence and absence of high sodium could also play an
important role in understanding the etiology of hypertension.
In conclusion, the HT AGM is a highly translational large animal model of
spontaneous hypertension that may provide unique clues to the etiology of essential
hypertension in humans. In light of the American Heart Association’s new
recommendations that will drastically increase the number of patients being treated for
hypertension, novel animal models represent an opportunity to identify new targets and
expand treatment options. Our work suggests that spontaneous hypertension in the AGM
may be driven by excess SNA and altered ADR function and provides evidence to support
exploration of this hypothesis. Sympathetic tone, response of blood pressure and oxidative
stress to adrenergic blockade, and the effects of renal denervation should be studied in this
translational non-human primate model of spontaneous hypertension to further test this
hypothesis.
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Table 4.1. Forward and Reverse Primer Sequences

Gene

Primer

Sequence

ADR α1A

Forward

5’-TCA TGT ACT GCC GCG TCT AC-3’

Reverse

5’-CGA GAA GTG CGT CTT GGT CT-3’

ADR α1D

Forward

5’-TGA GAA ACA CTG CCC CAT CC-3’

Reverse

5’-ACT GGG TTA GCC GAC CAA AG-3’

ADR α2A

Forward

5’-AGA GGA TTA CCT AGC CCT GG-3’

Reverse

5’-GCT GCC CTG AGT GGG TTT TA-3’

ADR α2C

Forward

5’-TAC TGG TAC TTC GGG CAG GT-3’

Reverse

5’-CGA TCG ACG AGG TGC AAA AC-3’

ADR β1

Forward

5’-CGC CCC GGA ACG ACT T-3’

Reverse

5’-TCA GAC GAG GAT TGT GGG CT-3’

ADR β2

Forward

5’-CCC TTA TCT ACT GCC GGA GC-3’

Reverse

5’-TGT GTT GCC ATT GCT GTT GC-3’

RPS 13A

Forward

5’-CCT GGA GGA GAA GAG GAA AGA
GA-3’

Reverse

5’-TTG AGG ACC TCT GTG TAT TTG TCA
A-3’

RPS 32

Forward
Reverse

5’-CAA CAT TGG TTA TGG AAG CAA CA3’
5’-TGA CGT TGT GGA CCA GGA ACT-3’
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Figure 4.1: Average blood pressures of animals used in the qPCR cohort.

Systolic (SBP), diastolic (DBP), and mean blood pressures (MBP) are elevated in the
hypertensive (n=18) animals in the qPCR and histology cohort compared to the
normotensive animals. * denotes p<0.05 compared to normotensive group using ANOVA
with Tukey’s post hoc analysis.
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Figure 4.2: Hypertensive animals display left ventricular hypertrophy compared to
normotensive animals.
Figure 4.2A: Cardiomyocyte cross-sectional area is elevated in the left ventricle of
hypertensive African green monkeys. Cross sectional area is similar in the right ventricle
between normotensive and hypertensive groups. Figure 4.2B shows representative
cardiac histological images from each group. * denotes p<0.05 compared to
normotensive group using ANOVA with Tukey’s post hoc analysis.
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Figure 4.3: β1 adrenoreceptor mRNA expression is elevated in the left ventricular
myocardial tissue of hypertensive African green monkeys.
ADRα1A, ADRα1D, ADRα2A, ADRα2C (A), and ADRβ2 (B) gene expression was
similar in normotensive and hypertensive left ventricular myocardium. * denotes p<0.05
compared to normotensive animals using Mann-Whitney U test.
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Figure 4.4: Renal cortical adrenergic receptor gene expression in HT and NT AGMs.
Renal cortical gene expression of ADRα1A, ADRα1D, ADRα2A, ADRα2C (A), ADRβ1
and ADRβ2 (B) is similar in normotensive and hypertensive African green monkeys.
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Figure 4.5: Adrenergic receptor gene expression is elevated in the renal outer medulla of
HT AGMs.
Renal outer medullary gene expression of all assessed α- and β-adrenoreceptor subtypes
is elevated in hypertensive African green monkeys compared to normotensive controls.
* denotes p<0.05 compared to normotensive animals using Mann-Whitney U test.
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Figure 4.6: Renal inner medullary ADRβ2 expression is elevated in HT AGMs.
Renal inner medullary gene expression of ADRα1A, ADRα1D, ADRα2A, ADRα2C (A),
and ADRβ1 (B) is similar between normotensive and hypertensive African green
monkeys. ADRβ2 gene expression is elevated in the renal inner medulla of hypertensive
African green monkeys compared to normotensive controls. * denotes p<0.05 compared
to normotensive animals using Mann-Whitney U test.
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5.1 Introduction
Aging has long been identified as a risk factor for the development of
hypertension, cardiovascular disease, stroke, chronic kidney disease, and other
cardiovascular pathologies. Globally, 31.1% (95% confidence interval, 30.0 -32.2%) of
the adult population has hypertension, as defined by systolic blood pressure > 140mmHg,
diastolic blood pressure >90 mmHg, or use of antihypertensive medications (Mills,
Bundy et al. 2016). In the United States, the prevalence of hypertension increases from
7.3% in adults aged 18-39 years to 64.9% in adults over 60 years old (Yoon, Frayer et al.
2015). Currently, the annual direct and indirect healthcare costs of hypertension are
estimated to be $53.2 billion and are projected to reach $220.9 billion by 2035
(Benjamin, Virani et al. 2018). As larger numbers of the US population age, increased
healthcare burdens will need to be met with new techniques and approaches to treat
disease pathologies that are exacerbated by aging (Knickman and Snell 2002). To this
end, the authors believe that basic science researchers need to be highly cognizant of age
as a key biological variable in the study of the etiology of hypertension. This work seeks
to elucidate the effect of age on the development of hypertension and renal dysfunction in
the spontaneously hypertensive AGM.
Aging has multiple effects on organ systems, organ function, and the response of
individual structures and cells within each organ. In the kidney, renal cortical mass and
glomerular filtration rate (GFR) decrease with age in healthy human volunteers (Karam
and Tuazon 2013). Classical inulin clearance studies found that GFR decreases 8
mL/min/1.73 m2 each decade after 30 years of age, though there are substantial individual
variations in the age-related declines of GFR (Weinstein and Anderson 2010). Autopsy
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analysis of adult kidneys (all presumably healthy without diagnosed renal disease)
indicates that glomerular number decreases with age, likely due to increased numbers of
sclerosed glomeruli (Hoy, Douglas-Denton et al. 2003). While glomerular number
decreases with age, unaffected nephrons may undergo hypertrophy as a compensatory
mechanism with increased tuft cross-sectional area, thickening of the basement
membrane, and mesangial cell expansion (Denic, Glassock et al. 2016). Changes in renal
hemodynamics, such as reductions in renal blood flow and GFR, have been observed in
healthy, aged subjects. One study found that in young healthy subjects (ages 19-32),
maximal renal vasodilation, as induced by concurrent infusion of amino acids and
dopamine, results in a significant increase in both renal blood flow and GFR, known as
the renal hemodynamic and functional reserves, respectively. However, in healthy, older
subjects (ages 65-76), renal hemodynamic and functional reserves are diminished in
comparison to the younger age group (Fuiano, Sund et al. 2001).
Changes in urinary protein excretion and renal electrolyte handling are also
associated with increased age (Frame and Wainford 2018). Proteinuria, a clinical marker
of renal damage, is associated with increased rates of all-cause mortality, cardiovascular
disease, and congestive heart failure in the United States and other developed nations
(Muntner, He et al. 2002, Irie, Iso et al. 2006). The activity of Na+-K+-ATPase, a key
driver of tubular sodium transport, is differentially distributed throughout the nephron
during aging in Sabra rats. Na+-K+-ATPase activity increases in the proximal tubule and
cortical collecting duct while decreasing in the medullary thick ascending limb and distal
convoluted tubule as animals age (Scherzer, Gal-Moscovici et al. 2015).
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Aging is associated with the impairment of vascular endothelial function, as
measured by the vasodilatory response to acetylcholine, in both normotensive and
essential hypertensive patients (Taddei, Virdis et al. 1995). This study found that normal
aging without the presence of cardiovascular pathologies was associated with alterations
in the response to cholinergic stimulation. Tanaka et al found that central arterial
compliance, a measure of the cardiothoracic circulation’s ability to expand and recoil
with cardiac pulsation, decreased with age even in healthy, physically active men
(Tanaka, Dinenno et al. 2000). These key structural changes that occur with healthy aging
greatly increase the possibility of renal damage with aging that is compounded with
elevated blood pressure.
This work seeks to determine the effect of age on the prevalence of hypertension
in the African green monkey (AGM), a novel non-human primate model of spontaneous
hypertension. Wild-caught animals residing in a research colony underwent
comprehensive physical examinations and behavioral observations to assign highly
confident age estimates. Next, 24 hour urine collection studies were conducted to assess
glomerular filtration rates in young and aged AGMs with both normal and elevated blood
pressures. Finally, urinary protein and electrolyte excretion rates were compared to
determine effects of age and blood pressure on renal function.
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5.2 Methods

5.2.1 Animal care and housing
Animal protocols strictly adhere to both the NIH Guide on the Care and Use of
Laboratory Animals(Animals 2011) and “Guiding Principles on the Care and Use of
Experimental Animals” published by the American Physiological Society. Protocols were
reviewed and approved by the Institutional Animals Care and Use Committee (IACUC)
of the Biomedical Sciences Research Group and SKN Primates in Basseterre, St. Kitts
and Nevis, West Indies. Animals were housed in the long term in troop enclosures in a
large outdoor facility in St. Kitts, West Indies. Animals were fed nonhuman primate
chow (Teklad 8773, Harlan) daily and a seasonal combination of fresh fruit and
vegetables (bananas, mangos, sweet potatoes, carrots and squash) on alternating days.
Water was provided ad libitum. Quarantine and husbandry protocols were maintained as
previously described (Rhoads, Goleva et al. 2017).

5.2.2 Blood pressure measurements
Animals were sedated (ketamine, 15mg/kg i.m.) and blood pressure measured as
described previously in detail (Rhoads, Goleva et al. 2017). After sedation, animals were
placed in a supine position and a blood pressure cuff placed on the left upper arm. A
Doppler stethoscope was used to confirm total occlusion and identify Korotkoff sounds
indicative of systolic (SBP) and diastolic blood pressures (DBP). Animals were
characterized as normotensive (NT, SBP ≤ 120 mmHg), pre-hypertensive (PHT, SBP
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between 120 and 140 mmHg), or hypertensive (HT, SBP ≥ 140 mmHg) based on
repeated measurements of SBP. Mean blood pressure (MBP) were calculated by the
equation: 𝑀𝐵𝑃 =

G-HI(L-H∗J)
M

5.2.3 Age estimations
Highly confident age estimates (n=304) were determined by animal husbandry
staff with over 50 years of combined experience working with AGMs. Estimates took
into account animal behavior, weight, incisor length, fur coarseness, crown-rump ratio,
tail stiffness, and troop hierarchy positioning to determine a reasonable approximation of
the animal’s age. Adult animals were binned into one of four age categories: “juvenile”
estimated 0-4 years old; “young adult” estimated 5-10 years old; “adult” estimated 11-15
years old; or “mature adult” estimated 16+ years old. Animals whose age could not be
confidently estimated were removed from analysis.

5.2.4 Urine collection and sample preparation
Prior to study, animals were moved from group enclosures into singly housed
metabolic pens with 1 L water bottles for the duration of the studies (n=112). The dietary
regimen remained the same, with animals being fed non-human primate chow (Teklad
8773, Harlan), fresh fruits, and vegetables as described above. Female animals were
monitored and examined for pregnancy, and if found to be pregnant, were removed from
this cohort. After a minimum 7-day acclimation period, blood pressures were measured
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as described above and whole blood collected in Li-heparinized tubes. Urine was then
collected for 3 consecutive, 24-hour periods. Water intake and urine volume were
recorded daily. Urine samples were centrifuged (1000xg) to remove any large particulate
contaminants. Samples were aliquoted into 1.5 mL tubes to minimize freeze-thaw cycles
during further downstream analysis and stored at -20°C. Juvenile animals were not used
in 24-hour urine collection experiments as the effect of sexual maturation on renal
function in the AGM is unknown and outside the scope of this work.

5.2.5 Urinary protein measurement
Total protein concentration was measured by Pierce BCA Assay (Catalog #
23225, ThermoFisher Scientific, Waltham MA) per the manufacturer’s recommended
protocol. Briefly, urine samples were diluted 1:4 and 25 μL of bovine standard albumin
or thawed samples were pipetted in a microplate. Working BCA reagent (200 ul) was
added to each well and the plate incubated at 37°C for 2 hours. After cooling to room
temperature, absorbance was read at 595nm. A linear standard curve was generated (r2 ≥
0.98) and used to determine protein concentration for the unknown samples.

5.2.6 Estimation of glomerular filtration rate
Urinary creatinine was measured by a modified Jaffe reaction(Husdan and
Rapoport 1967) or by plasma creatinine assay following the manufacturer’s
recommended protocol (Item #: 700460, Cayman Chemical, Ann Arbor, MI). Urine
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samples were diluted 20x. Briefly, known creatinine standard or thawed, diluted urine
samples (50 ul) were combined with 100 μL of alkaline picrate (12.5 mL of 0.13% picric
acid and 2.5mL of 1 M NaOH). After 30-minute room temperature incubation,
absorbance was read at 490 nm. A linear standard curve was generated (r2 ≥ 0.98) and
used to determine creatinine concentration for the unknown samples. Estimated
glomerular filtration rate (eGFR) was calculated by the equation

𝑒𝐺𝐹𝑅 =

𝑈𝑟𝑖𝑛𝑒 𝐹𝑙𝑜𝑤 𝑅𝑎𝑡𝑒 𝑥 𝑈𝑟𝑖𝑛𝑒<=>?@ABAB>
𝑃𝑙𝑎𝑠𝑚𝑎<=>?@ABAB>

5.2.7 Urinary sodium and potassium concentration
Urinary sodium and potassium concentrations were measured by dual-channel
flame photometry (Dual-channel flame photometer #02655-10, Cole-Parmer, Vernon
Hills, IL). Thawed urine samples were diluted 20X in lithium diluent and concentrations
multiplied by dilution factor, molecular weight, and the appropriate urine flow rate (UFR)
to obtain ion excretion rates.
5.2.8 Statistical analysis
Data was analyzed using SPSS 23 (IBM) and groups were compared by two-way
ANOVA with Bonferroni adjustment. If no interactions were found between the two
independent variables, a one-way ANOVA with Tukey’s post hoc comparison was used
for comparison. 95% confidence intervals were calculated using the Wilson score method
and compared using a Chi square test of independence. Values are presented as mean ±
SEM and p<0.05 used as the criterion of significance.
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5.3 Results
Young adult animals (n=86) display lower systolic (129.1±3.3 mmHg), diastolic
(51.4±1.9 mmHg), and mean blood pressures (77.3±2.1 mmHg) compared to both adult
(n=21; SBP: 151±7.2 mmHg, DBP: 66.6±4.4 mmHg, MBP: 94.7±4.5 mmHg) and mature
adult (n=5; SBP: 164.2±23 mmHg, DBP: 72.8±14.4 mmHg, MBP: 103.3±17.1 mmHg)
AGMs (p<0.05, ANOVA with Tukey’s post hoc comparison, Figure 1). There were no
significant interactions between age and phenotype for systolic, diastolic, or mean blood
pressures (p>0.05, two-way ANOVA).
Adult animals (5.3±0.9 kg) weighed significantly more than young adult animals
(4.3±0.9 kg, p<0.05 by Tukey’s post hoc comparison). Mature adult animals had an
average weight of 5.0±1.2 kg and were similar to both young adult and adult groups
(Figure 2A). No significant interactions were found for weight between age and
phenotype groups (Figure 2B). Values for subgroups can be found in Table 1, while
values for phenotypic groups have already been discussed in Chapter 3.
The average prevalence of hypertension in the entire AGM cohort (n= 424) is
37% as previously reported (Rhoads, Goleva et al. 2017). Only animals with known ages
or highly confident age estimates were included in the prevalence analysis (n=304). In the
juvenile age group (n=15), 20% (95% CI, 7.05 to 45.19%) of AGMs display SBPs
greater than 140 mmHg, while 31.34% (25.33 to 38.06%) of the young adult (n=201)
animals are considered HT. In the adult (n=60) group, 48.33% (36.18 to 60.69%) of the
AGMs are HT and prevalence increases to 60.7% (42.41 to 76.43%) in the mature adult
(n=28) group. The prevalence of hypertension is significantly increased in the adult and
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mature adult age groups compared to the juvenile and young adult age groups (Figure 3
& Table 2, p<0.05).
There were no significant differences in water intake between any age, phenotype,
or age/phenotype subgroups (Figure 4A & 4B). Young adult animals (n=86) drank on
average 224.8±19.0 mL/day, while adult animals (n=21) drank 223.6±32.5 mL/day.
Mature adult animals (n=5) drank 322.7±126.9 mL/day of water. Urine flow rate (UFR)
was similar between all age groups, phenotype groups, and subgroups (Figure 4C & 4D).
Young adult animals had an average UFR of 152.7±11.7 mL/day. Adult animals had an
average UFR of 162.5 mL/day while mature adult AGMs had a mean urine volume of
137.5±37.8 mL/day.
eGFR was similar between all comparisons of age and phenotype (Figure 5A & 5
B). Young adult animals (n=63) had a mean eGFR of 3.9±0.3 mL/min while adult
animals (n=17) had an estimated GFR of 4.9±0.7 mL/min. Mature adult animals (n=5)
had an average eGFR of 4.4±1.5mL/min.
Young adult animals had an average daily protein excretion rate of 396.5±16.1
mg/day, while adult animals had an average protein excretion rate of 458.2±36.8 mg/day.
Mature adult animals excreted 427.1±36.8 mg/day of protein (Figure 6A). There was a
statistically significant interaction between phenotype and age on protein excretion rate,
F(4, 101)=3.735, p = 0.007, partial η2=0.129. Thus, an analysis of simple main effects
was performed for age with a Bonferroni adjustment for multiple comparisons. A
significant difference was found between blood pressure phenotypes for young adult
animals, F(2,101)=3.664, p=0.029, partial η2=0.068; adult animals, F(2,101)=4.739,
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p=0.011, partial η2=0.086; and mature adult animals, F(2,101)=5.348, p=0.006, partial
η2=0.096. Within the young adult AGM group, HT animals have significantly elevated
protein excretion rates compared to NT animals (NT 346.5±21 mg/day vs. HT
440.7±30.0 mg/day, p=0.037). In the adult group, HT animals have significantly elevated
protein excretion rates compared to BHT AGMs (BHT 347.5±52.9 mg/day vs. HT
540.9±44.2 mg/day, p=0.023). In the mature adult group, the BHT animal had elevated
protein excretion (810.9 mg/day) compared to the NT animal (176.5 mg/day, p=0.006)
and the HT group (382.6±39.2 mg/day, p=0.031, Figure 6B).
Sodium excretion rates (Figure 7A & 7B) were significantly elevated in adult
animals (3.9±0.4 mmol/day) compared to young adult animals (2.7±0.2 mmol/day,
p=0.006). Daily sodium excretion in mature adult animals was not significantly different
compared to either age group (2.2±0.5 mmol/day). Potassium excretion rates were similar
in all age, phenotype, and subgroup comparisons. Young adult animals excreted 3.3±0.3
mmol/day of potassium, while adult AGMs excreted 3.8±0.4 mmol/day of potassium.
Mature adult AGMs had an average potassium excretion rate of 3.6±1.1 mmol/day.
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5.4 Discussion
A major finding in this work is that the prevalence of hypertension increases with
age in the African green monkey. 20% of juvenile animals display SBPs >140mmHg and
the prevalence of hypertension increases to 31.3%, 48.3%, and 60.7% in young adult,
adult, and mature adult animals, respectively (Table 2). The adult and mature adult
groups have a significantly elevated prevalence of hypertension compared to the younger
two groups, demonstrating that age may contribute to the development of hypertension in
this non-human primate model. In addition, average SBP, DBP, and MBPs are higher in
the adult and mature adult age groups compared to the young adult group, suggesting that
blood pressure increases with age in this model species. Data from both human studies
and experimental animal models illustrates that many pathophysiological changes occur
with aging that promote the development of hypertension, including, but not limited to,
reduced arterial compliance, endothelial dysfunction, reductions in renal blood flow,
alterations in GFR, glomerular morphology, and renal sodium handling, as previously
described.
Weight is increased in the adult age group compared to the young adult age
group. While not a novel finding, this increased body mass may explain the increased
sodium excretion rate between the same two groups. Larger animals should, in theory,
consume more food and thus excrete more sodium. However, as previously discussed,
this interpretation is limited until more precise methods of estimating food and sodium
intake in this model organism are available. The lack of significant differences in water
intake and UFR between age groups suggests that AGMs are able to maintain water
balance regardless of age.
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eGFR decreases normally with age in human populations and is considered
predictive of mortality, development of cardiovascular disease, and a key clinical
indicator of chronic kidney disease. However, eGFR was similar in all age groups in this
study and in prior studies that investigated blood pressure phenotype and sex. Interindividual variation in eGFR is common in patient populations and some variation is
expected in an outbred population of animals. However, the usage of creatinine for
estimation of GFR has been called into question (Lamb, Wood et al. 2005). Some studies
have shown that creatinine is limited in estimation of GFR since creatinine serum levels
can vary widely with disease states, muscle mass, and nutritional status (Hoek,
Kemperman et al. 2003). In addition, creatinine can be secreted from tubules in
glomerulopathic disease states, causing unpredictable estimates of GFR (Shemesh,
Golbetz et al. 1985). It is entirely possible that the methods used in this study may not
accurately estimate GFR in the AGM. Future studies in the AGM should utilize other
methods of eGFR measurement, such as FITC-sinistrin, serum cystatin C, or classical
inulin clearance, in order to confidently determine the effect of age, sex, and blood
pressure on eGFR.
Urinary protein excretion is elevated in young adult HT animals compared to agematched NT controls. In the adult age group, HT animals had elevated protein excretion
compared to age-matched BHTs. Interestingly, average protein excretion was nearly
identical in both NT and BHT adults, however, the small group size of the NT adult
AGMs (n=3), likely interfered with statistical comparison of the age/phenotype groups.
More NT animals in the 11-15 year old age group, as well as more mature adult animals,
should undergo 24-hour urine collections in order to accurately draw conclusions on the
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effect of age and elevation of blood pressure on renal damage in the AGM. Proteinuria is
an important clinical marker of renal damage in patients. In aging male Wistar rats,
protein excretion remains relatively stable until senescence, approximately 38 months of
age, where it greatly increases. However, albumin excretion increases with age as early as
12 months of age, suggesting of increased glomerular permeability at a relatively young
age(Alt, Hackbarth et al. 1980). Future studies that assess albumin excretion, and thus
indirectly glomerular permeability, in the context of age and elevated blood pressure
would provide crucial information regarding the pathogenesis of hypertension in the
AGM.
A major limitation in this study is the small sample size of the mature adult group
(n=5). Animals that are 16+ years old are rare to find in the St. Kitts habitat, perhaps due
to territorial disputes between troops, hunting by man, and natural causes of death.
Currently, the authors are working with the local government and trappers to procure
additional animals for study. In addition, the authors are also breeding and maintaining
animals that will be used to directly assess the longitudinal effects of age and
hypertension in a larger cohort of AGMs, as well as track the development of
hypertension throughout the lifespan of the species in captivity.
In conclusion, hypertension prevalence increases with age in the African green
monkey, similar to human populations, without specialized diets, breeding paradigms, or
experimental interventions. Urinary protein excretion, a clinical marker of renal damage,
is increased in young adult hypertensive animals compared to age-matched normotensive
controls. While the exact mechanisms that promote the development of hypertension in
young and old AGMs are currently unknown, future studies will attempt to determine key
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differences in normotensive and hypertensive animals within all age groups. The African
green monkey represents a unique model system for studying the effect of age on the
development and maintenance of hypertension and associated cardiovascular diseases
with a high translational capacity.
Perspectives and Significance
The recent blood pressure guidelines from the American Heart Association and
the American College of Cardiology lower target systolic and diastolic blood pressures
for the diagnosis of hypertension to 130 mmHg and 80 mmHg, respectively (Whelton,
Carey et al. 2018). These new guidelines will result in an estimated 46% of adult in the
U.S. being diagnosed with high blood pressure, though ‘newly diagnosed’ Stage I
hypertensive patients are recommended for non-pharmacological therapy in most
circumstances. Analysis of the effects of age and sex in the development of hypertension
in a highly translational model organism will give researchers new tools to study and
facilitate the identification of newer and more effect treatments and targets as the
healthcare burden of hypertension increases.
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Table 5.1: Mean and SEMs for each age/phenotype group
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Table 5.2: Prevalence of hypertension in the African Green Monkey by age
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Figure 5.1:Blood pressure by age in the AGM.
Young adult (aged 5-10 years) have lower systolic, diastolic, and
mean blood pressures compared to adult (aged 5-10 years) and
mature adult (16+ years) groups (p<0.05, ANOVA with Tukey’s
post hoc comparison).
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Figure 5.2: Adults animals are larger than young adult animals.
Adult animals (aged 11-15 years) are significantly larger than young
adult animals (aged 5-10 years, p<0.05, ANOVA with Tukey’s post
hoc comparison). Mature adult animals (aged 16+ years) had
weights similar to the other age groups. No significant interactions
between age and phenotype were found (2B).
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Figure 5.3: Hypertension prevalence increases with age in the African
Green Monkey.
Adult (aged 11-15 years) and mature adult (aged 16+ years) animals
have significantly increased rates of hypertension compared to
juvenile (aged 0-4 years) and young adult (aged 5-10 years) animals.
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Figure 5.4: Water balance is similar between all age groups.
Water intake and urine flow rates are similar between age groups and
age/phenotype groups (p>0.05, ANOVA with Tukey’s post hoc comparison) and
no significant interactions exist between age and phenotype group (p>0.05, twoway ANOVA).
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Figure 5.5: eGFR is similar between all age groups.
Estimated glomerular filtration rates are similar between age groups and
age/phenotype groups (p>0.05, ANOVA with Tukey’s post hoc comparison) and
no significant interactions exist between age and phenotype group (p>0.05, twoway ANOVA).
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Figure 5.6: Urinary protein excretion is altered by age and phenotype in the
AGM.
Protein excretion is significantly affected by age and blood pressure phenotype
(p<0.05, two-way ANOVA). In the young adult age group, protein excretion is
elevated in HT animals compared to NT animals. In the adult age group, HT
animals have elevated protein excretion compared to BHT animals. In the mature
adult group, the BHT animal has significantly elevated protein excretion
compared to both the NT animal and the HT animals. # denotes p<0.05
compared to age-matched NT; & denotes p<0.05 compared to age-matched BHT
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Figure 5.7: Urinary sodium excretion is elevated in adult animals compared to
young animals.
Sodium excretion is elevated in adult (aged 11-15 years) animals compared to
young adult (aged 5-10 years) animals (p<0.05 ANOVA with Tukey’s post hoc
comparison). Potassium excretion is similar in all age and age/phenotype
groups.
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CHAPTER SIX
DISCUSSION AND CONCLUSIONS
The African Green Monkey (AGM) is a highly translational large animal of
spontaneous hypertension. It is a novel non-human primate model for a complex
multifactorial disease that affects the health and life expectancy of one in three adults in
the United States. While rodent models of disease have contributed largely to our
understanding of hypertension and disease, 13% of hypertensive patients maintain
elevated blood pressures while on three or more classes of anti-hypertensive
therapies(Persell 2011). In 2015, over 78,000 deaths in the United States were directly
attributed to hypertension (Benjamin, Virani et al. 2018), highlighting the detrimental
health risks of this pathology that is expected to exceed $200 billion in direct spending by
2030.
Utilization of a non-human primate model of spontaneous hypertension offers
specific advantages over traditional rodent models. AGMs are diurnal, like humans. Their
upright posture allows for cyclical unloading of baroreceptors that resembles human
physiology, unlike quadruped models. AGMs share over 90% of their gene sequence with
humans and the two genomes have very high levels of synteny (Jasinska, Service et al.
2007). Unlike the closely-related rhesus monkey, the AGM is not endangered, easier to
obtain, and typically less expensive to purchase (Jasinska, Schmitt et al. 2013). Compared
to human studies, complex variables such as diet, reproduction, social interactions, and
environmental factors can be controlled in this laboratory model. Large-scale genetic
tools are becoming increasingly available for the analysis of complex diseases and traits
(Huang, Ramensky et al. 2015), while their highly similar physiology to humans makes
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them ideal for studies utilizing pharmacologic or physiological manipulations. The renal
and cardiac pathologies reported in this dissertation strengthen the translational capacity
of this model in the study of hypertension and associated cardiovascular diseases – as the
hypertensive AGM exhibits several pathologies similar to essential hypertensive patients.
Like any model, the AGM has limitations. Due to their larger size compared to
rodents, the associated costs of care and procurement are higher. As highly social
creatures, they thrive in large group enclosures, which can be difficult for long-term
maintenance and upkeep. Renal function studies, as previously described, require single
housing, which may induce a stress response after removal from group housing. While
any animal exhibiting signs of extreme distress is removed from single housing and all
efforts are made to minimize stress for each animal, this induced stress is a confounding
factor that should be considered in the interpretation of these results. Like any animal
model, the AGM cannot recapitulate every clinical phenotype, however, the clinical
relevance and importance of novel, unique, translational models in research cannot be
understated. It is crucial that basic research scientists understand the mechanisms and
factors that contribute to the development of pathologies as well as how disease processes
are recapitulated in experimental animal models. The AGM represents an important
opportunity for basic researchers to identify and study mechanisms of blood pressure
control that may be unique to primates alone.
This dissertation details the first description of end-organ damage associated with
hypertension in the AGM. In a cohort of 424 adult animals, 37% of the animals displayed
systolic blood pressures over 140 mmHg while under light sedation. This rate of
prevalence in the AGM is similar to the recent estimation from the American Heart
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Association that 31.1% of adults in the United States have hypertension (reference?),
however, there are important considerations to this interpretation. First, while genetic
variability in the United States is quite heterogeneous, the AGM in the Caribbean likely
has a relatively homogeneous level of genetic variability. Introduction of the AGM to the
Caribbean likely occurred in the 1600s when the animals were brought to the islands as
pets in the shipping trade. Long and stressful sea journeys likely had low survival rates
that may have limited the genetic variability of the founding members of the population.
Thus, the Caribbean AGM has likely undergone a significant bottleneck effect, which
may influence the prevalence of hypertension described in the study. Analysis of the
prevalence of hypertension in the Gambian population from which the Caribbean AGM
(Svardal, Jasinska et al. 2017) is descended would provide data that clarify and provide
context for the interpretation of this finding. Namely, it should be determined if the entire
genus suffers from hypertension or if the introduction event of the AGM to the Caribbean
selected for genes that promote hypertension. Rates of hypertension in humans are high
in St. Kitts and Nevis (it was recently estimated that 53% of adults in the island country
are hypertensive (Crews, Campbell et al. 2017) ), so it is possible that the increased rates
of hypertension in both human and nonhuman primates may be partially attributed to
high levels of salt in the diet due to location. Additional experiments designed to test
these hypotheses are worth exploring.
The prevalence of hypertension increases with age in the AGM. Aging is a major
risk factor for the development of hypertension and cardiovascular disease in humans as
vascular stiffness and sclerosis increase with age. The data in this dissertation do show an
association of the prevalence of hypertension with age, but the mechanisms controlling
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this relationship have yet to be identified. It is worth noting that other studies have shown
development of atherosclerosis, insulin resistance, and obesity in the AGM, which are all
often co-morbidities with hypertension in older patients, particularly in the context of
obesity(references). Animals in the Caribbean research colony that we collaborate with
are not obese, but other research colonies induce obesity in the species via a Western diet
(Schmitt, Service et al. 2017). A comparative analysis of both the genetic and
environmental factors contributing to the elevation of blood pressure in young and old,
obese and non-obese AGMs would greatly enhance the translational capacity of the
model species.
Changes in glomerular morphology and renal vascular hypertrophy are markers of
renal damage associated with hypertension in the AGM. It is currently unknown if the
proteinuria inducing renal damage is primarily located in the glomerulus, tubule, or both
structures. Analysis of damage markers like vimentin or kidney injury molecule (LopezGiacoman and Madero 2015) would answer these questions and provide crucial data
about the pathogenesis of hypertension in the AGM. Renal function studies found that
HT AGMs have elevated urinary protein excretion compared to NT animals. Analysis of
urinary protein excretion by age revealed that the elevation of blood pressure is
associated with greater levels of proteinuria in young adult animals, which made up a
larger majority of the renal function study cohort. Additional renal function studies
focused on adult and mature adult animals will be an important contribution to the body
of knowledge on the interaction of age and blood pressure elevation in the AGM.
Urinary sodium excretion is elevated in hypertensive animals, likely due to
natriuresis in response to elevated blood pressure. Real-time blood pressure
140

measurements (obtained via wireless radio-telemetry) in association with shorter, more
precise urine collection periods would determine how time of day, food intake, and
activity would affect both blood pressure and natriuresis in the AGM. It is worth noting
that, exact sodium intake is difficult to calculate with the current experimental equipment
as primate chow can be thrown out of the cage or lost in the process of eating. New
techniques and methods to accurately assess food intake will be needed to overcome this
limitation.
Increased gene expression of adrenergic receptors in the renal medulla and left
ventricular myocardium in the HT AGM suggests that sympathetic activation plays a role
in the development and maintenance of hypertension in this model organism. Elevated
heart rate, a possible consequence of increased sympathetic drive, and cardiac
hypertrophy, associated with activation of the cardiac β-adrenergic receptors, were also
associated with hypertension in the AGM. It is possible that sympathetic activation is
elevated in the AGM increasing total peripheral resistance, and thus afterload, which
could be assessed by measurement of sympathetic tone via ganglionic blockade or
administration of selective α- and β-adrenergic receptor antagonists. It is also possible
that decreased renal sympathetic nerve activation has increased renal adrenergic receptor
transcription. Assessment of renal sympathetic activation via renal denervation or
selective afferent nerve ablation would clarify the contribution of the sympathetic
nervous system in this possibly neurogenic model of hypertension.
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Additionally, prior studies demonstrated that hypertension in the AGM was
ameliorated by administration of captopril, an ACE inhibitor, and not furosemide, a loop
diuretic, suggesting activation of the renin-angiotensin-aldosterone system may be
associated with hypertension in the AGM(Martin, Palmour et al. 1990). Our reported
measurements of similar plasma renin activity, liver angiotensin expression, and renal
cortical renin content suggest that the AGM is a ‘normal-renin’ model of hypertension.
Assuming that the HT AGM in our hands responds to captopril with decreases in blood
pressure, this suggests that other mechanisms, such as activation of RAAS in the central
nervous system, may be contributing to the hypertension seen in this model. These
model-defining experiments are crucially important to the determination of the
mechanism causing hypertension in this unique animal model. However, downstream
measurement of additional components of the RAAS, such as aldosterone, have not been
published to date. It is also possible that alternate enzymes, such as chymase, that
catalyze the formation of Ang II are increased in the HT AGM.
The possibility that a unique gene or gene variant may be causal in the
development of hypertension in this model cannot be ignored. The unique history in the
founding of the Caribbean AGMs may have resulted in high frequencies of detrimental
genes in the population which result in an increased risk of hypertension. Future studies
to further characterize the AGM as a model of spontaneous hypertension include, but are
not limited to, long-term studies that measure the development of hypertension and the
progression of end-organ damage throughout life, radio-telemetric measurement of blood
pressure in conscious group-housed animals, further characterization of the reninangiotensin-aldosterone system, the effect of renal denervation in the AGM, the
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pharmacological effects of anti-hypertensive medications in the AGM and genetic and
epidemiological analysis of the Caribbean and African populations of the AGM.
The complex social hierarchy in the AGM (Dunbar 1974) represents a unique
opportunity to study the effects of psychosocial stress on severity and pathogenesis of
hypertension in a large animal model similar to humans. Social stress, such as work
stress, is increasingly being recognized as important in the pathogenesis of cardiovascular
disease (Thayer, Yamamoto et al. 2010). As AGMs exist in multi-male and multi-female
groups in the wild, social hierarchies are complex and have long-term effects on
reproductive success in both males and females (Fairbanks and McGuire 1986, Isbell,
Cheney et al. 2002, Seyfarth and Cheney 2003). Dominance in the male AGM is
associated with increased paternity success (Weingrill, Willems et al. 2010), and
decreased plasma norepinephrine levels (Dillon, Raleigh et al. 1992) but no studies have
been published assessing the relationship between blood pressure and hierarchy status in
the AGM. While complex social organization is not unique to primates, a prolonged
period of dependence and learning is unique to primates. In addition, Old World monkeys
and humans share similar patterns and rates of limbic and cortical brain development
(Palmour, Mulligan et al. 1997). The AGM provides a unique opportunity to investigate
the effects of these complex behaviors on health and disease in well-described social
hierarchies in a laboratory setting.
Within this dissertation, I have presented evidence that supports the hypothesis
that the African Green Monkey is a novel translational non-human primate model of
spontaneous hypertension that recapitulates the pathologies observed in hypertensive
human patients. The AGM is a novel tool in the investigation of hypertension that may
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increase the translational success of anti-hypertensive therapies and interventions and the
increased utilization of this model for basic science research may discover mechanisms of
blood pressure control unique to primates. Our data (Rhoads, Goleva et al. 2017)
combined with that of others (Martin, Palmour et al. 1990) suggests that hypertension in
the AGM is non-renin dependent but that elevated blood pressure is still sensitive to
captopril (an ACE inhibitor) administration, similar to many essential hypertensive
patients. In addition, our data support the idea that hypertension in the AGM is
sympathetically-driven.
The future of cardiovascular research in the AGM is bright and promising, as the
AGM is a large-animal model organism that can be utilized in many unique ways. As a
non-endangered, invasive pest species in the Caribbean, procurement of the animals
serves two main purposes – preservation of the agricultural business on the island (to
which the local AGM population is a large threat) and improved availability of the model
organism for scientific research purposes. Future research should further characterize the
response of the hypertensive AGM to anti-hypertensive pharmacological agents which
would create a useful profile for researchers to appropriately match this model to the
human drug responses seen in clinical practice and research.
Of course, as with any scientific research, the findings presented here have
created additional questions that need to be answered. It is currently unknown what
initiates the development of spontaneous hypertension in the AGM or what genetic
factors may contribute to the pathology. The temporal nature of the end-organ damage is
also unknown – does structural damage occur first, due to some mechanism other than
elevated pressure, or is the causal primary factor the elevation of blood pressure? Aging
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is associated with spontaneous hypertension in the AGM, but the role of sex has not yet
been elucidated. As the use of the AGM in blood pressure and cardiovascular research
increases, the answers to these questions and the immense translational potential of the
AGM will hopefully be realized.
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